Term	Accession	Genes (tot)	Stat (non-dir.) p	p adj (non-dir.)	Significant..in.gene.set.	Non.significant..in.gene.set.	Significant..not.in.gene.set.	Non.significant..not.in.gene.set.	effect.size
R-HSA-109606	Intrinsic Pathway for Apoptosis	 29	0.961236003533543	1	3	26	1255	4677	0.4901869415054
R-HSA-109688	Cleavage of Growing Transcript in the Termination Region 	 47	0.00199247576505844	0.423715563331436	19	28	1239	4675	1.91555322531543
R-HSA-109704	PI3K Cascade	 19	0.00238437466186949	0.423715563331436	10	9	1248	4694	2.49393356204502
R-HSA-110056	MAPK3 (ERK1) activation	  8	0.227769868815571	1	3	5	1255	4698	1.77692766295707
R-HSA-110312	Translesion synthesis by REV1	 13	0.287098043862492	1	4	9	1254	4694	1.45799192858016
R-HSA-110313	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template	 24	0.228880550792374	1	7	17	1251	4686	1.38205484896661
R-HSA-110314	Recognition of DNA damage by PCNA-containing replication complex	 20	0.826301872790362	1	3	17	1255	4686	0.71077106518283
R-HSA-110320	Translesion Synthesis by POLH	 13	0.538576769291448	1	3	10	1255	4693	1.09349394643512
R-HSA-110328	Recognition and association of DNA glycosylase with site containing an affected pyrimidine	  5	0.694448590316415	1	1	4	1257	4699	0.947694753577107
R-HSA-110329	Cleavage of the damaged pyrimidine 	  5	0.694448590316415	1	1	4	1257	4699	0.947694753577107
R-HSA-110362	POLB-Dependent Long Patch Base Excision Repair	  6	1	1	0	6	1258	4697	0
R-HSA-110373	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	 18	0.918744185015892	1	2	16	1256	4687	0.526497085320615
R-HSA-111367	SLBP independent Processing of Histone Pre-mRNAs	  6	0.758985808815735	1	1	5	1257	4698	0.789745627980922
R-HSA-111447	Activation of BAD and translocation to mitochondria 	 13	1	1	0	13	1258	4690	0
R-HSA-111453	BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members	  6	0.758985808815735	1	1	5	1257	4698	0.789745627980922
R-HSA-111465	Apoptotic cleavage of cellular proteins	 27	0.016135697275139	0.5974568991065	11	16	1247	4687	1.93048931284225
R-HSA-111885	Opioid Signalling	 67	0.783481270030319	1	12	55	1246	4648	0.848681868875021
R-HSA-111931	PKA-mediated phosphorylation of CREB	 16	0.446016886428218	1	4	12	1254	4691	1.18461844197138
R-HSA-111933	Calmodulin induced events	 22	0.312783404638284	1	6	16	1252	4687	1.29231102760515
R-HSA-111996	Ca-dependent events	 24	0.395993173232745	1	6	18	1252	4685	1.18461844197138
R-HSA-111997	CaM pathway	 22	0.312783404638284	1	6	16	1252	4687	1.29231102760515
R-HSA-112040	G-protein mediated events	 37	0.534107381514387	1	8	29	1250	4674	1.02453486873201
R-HSA-112043	PLC beta mediated events	 36	0.500031591261808	1	8	28	1250	4675	1.05299417064123
R-HSA-112308	Presynaptic depolarization and calcium channel opening	  9	1	1	0	9	1258	4694	0
R-HSA-112310	Neurotransmitter release cycle	 39	0.745295360857552	1	7	32	1251	4671	0.850495291671762
R-HSA-112311	Neurotransmitter clearance	  7	0.809900309657012	1	1	6	1257	4697	0.676924823983648
R-HSA-112382	Formation of RNA Pol II elongation complex 	 36	0.00411854372452668	0.423715563331436	15	21	1243	4682	1.97436406995231
R-HSA-112399	IRS-mediated signalling	 23	0.00383440369869762	0.423715563331436	11	12	1247	4691	2.26622658464091
R-HSA-112409	RAF-independent MAPK1/3 activation	 20	0.418741336951152	1	5	15	1253	4688	1.18461844197138
R-HSA-112411	MAPK1 (ERK2) activation	  9	0.291270746199599	1	3	6	1255	4697	1.57949125596184
R-HSA-112412	SOS-mediated signalling	  7	0.167421732949172	1	3	4	1255	4699	2.03077447195094
R-HSA-113418	Formation of the Early Elongation Complex	 19	0.0312926420674363	0.832120089163637	8	11	1250	4692	1.99514684963601
R-HSA-113501	Inhibition of replication initiation of damaged DNA by RB1/E2F1	  9	0.291270746199599	1	3	6	1255	4697	1.57949125596184
R-HSA-113507	E2F-enabled inhibition of pre-replication complex formation	  6	1	1	0	6	1258	4697	0
R-HSA-113510	E2F mediated regulation of DNA replication	 15	0.642500710250324	1	3	12	1255	4691	0.947694753577107
R-HSA-114452	Activation of BH3-only proteins	 22	0.873207475913891	1	3	19	1255	4684	0.646155513802573
R-HSA-114508	Effects of PIP2 hydrolysis	 20	0.826301872790362	1	3	17	1255	4686	0.71077106518283
R-HSA-114604	GPVI-mediated activation cascade	 27	0.852187264802933	1	4	23	1254	4680	0.70199611376082
R-HSA-114608	Platelet degranulation 	 82	0.850840839489787	1	14	68	1244	4635	0.809007716468262
R-HSA-1168372	Downstream signaling events of B Cell Receptor (BCR)	 65	0.837293788489508	1	11	54	1247	4649	0.80189556071909
R-HSA-1169091	Activation of NF-kappaB in B cells	 52	0.885544526382709	1	8	44	1250	4659	0.728995964290082
R-HSA-1169092	Activation of RAS in B cells	  5	0.694448590316415	1	1	4	1257	4699	0.947694753577107
R-HSA-1169408	ISG15 antiviral mechanism	 49	0.604093843963638	1	10	39	1248	4664	0.967035462833782
R-HSA-1169410	Antiviral mechanism by IFN-stimulated genes	 49	0.604093843963638	1	10	39	1248	4664	0.967035462833782
R-HSA-1170546	Prolactin receptor signaling	 10	0.656813358899076	1	2	8	1256	4695	0.947694753577107
R-HSA-1181150	Signaling by NODAL	  9	0.291270746199599	1	3	6	1255	4697	1.57949125596184
R-HSA-1187000	Fertilization	  7	0.167421732949172	1	3	4	1255	4699	2.03077447195094
R-HSA-1221632	Meiotic synapsis	 27	0.518839649379423	1	6	21	1252	4682	1.05299417064123
R-HSA-1222556	ROS, RNS production in phagocytes	 17	0.901691816657284	1	2	15	1256	4688	0.55746750210418
R-HSA-1226099	Signaling by FGFR in disease	 40	0.0295537222396884	0.832120089163637	14	26	1244	4677	1.65846581875994
R-HSA-1227986	Signaling by ERBB2	 39	0.860807015981936	1	6	33	1252	4670	0.728995964290082
R-HSA-1234158	Regulation of gene expression by Hypoxia-inducible Factor	  8	0.850065813595789	1	1	7	1257	4696	0.592309220985692
R-HSA-1234174	Regulation of Hypoxia-inducible Factor (HIF) by oxygen	 58	0.997006933608429	1	5	53	1253	4650	0.408489117921167
R-HSA-1234176	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	 52	0.997712345673983	1	4	48	1254	4655	0.364497982145041
R-HSA-1236382	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	 15	0.642500710250324	1	3	12	1255	4691	0.947694753577107
R-HSA-1236394	Signaling by ERBB4	 31	0.490255091512387	1	7	24	1251	4679	1.06997794758706
R-HSA-1236974	ER-Phagosome pathway	 64	0.821815251316774	1	11	53	1247	4650	0.814425178855326
R-HSA-1236975	Antigen processing-Cross presentation	 74	0.812811944424323	1	13	61	1245	4642	0.832434580844756
R-HSA-1236977	Endosomal/Vacuolar pathway	  8	0.528741782085573	1	2	6	1256	4697	1.18461844197138
R-HSA-1236978	Cross-presentation of soluble exogenous antigens (endosomes)	 38	0.9926072579238	1	3	35	1255	4668	0.374090034306753
R-HSA-1237044	Erythrocytes take up carbon dioxide and release oxygen	  9	0.881750209110067	1	1	8	1257	4695	0.526497085320615
R-HSA-1237112	Methionine salvage pathway	  5	0.694448590316415	1	1	4	1257	4699	0.947694753577107
R-HSA-1247673	Erythrocytes take up oxygen and release carbon dioxide	  6	1	1	0	6	1258	4697	0
R-HSA-1250196	SHC1 events in ERBB2 signaling	 17	0.728723766275771	1	3	14	1255	4689	0.83620125315627
R-HSA-1250342	PI3K events in ERBB4 signaling	  7	0.809900309657012	1	1	6	1257	4697	0.676924823983648
R-HSA-1250347	SHC1 events in ERBB4 signaling	 11	0.709604789044377	1	2	9	1256	4694	0.861540685070097
R-HSA-1251985	Nuclear signaling by ERBB4	 17	0.280104557481713	1	5	12	1253	4691	1.39366875526045
R-HSA-1253288	Downregulation of ERBB4 signaling	  5	1	1	0	5	1258	4698	0
R-HSA-1266695	Interleukin-7 signaling	 20	0.635673802887573	1	4	16	1254	4687	0.947694753577107
R-HSA-1268020	Mitochondrial protein import	 43	0.988487810464445	1	4	39	1254	4664	0.440788257477724
R-HSA-1295596	Spry regulation of FGF signaling	 11	0.419251923245224	1	3	8	1255	4695	1.29231102760515
R-HSA-1296041	Activation of G protein gated Potassium channels	 17	1	1	0	17	1258	4686	0
R-HSA-1296052	Ca2+ activated K+ channels	  7	0.453498803768073	1	2	5	1256	4698	1.3538496479673
R-HSA-1296059	G protein gated Potassium channels	 17	1	1	0	17	1258	4686	0
R-HSA-1296065	Inwardly rectifying K+ channels	 21	0.9931755161171	1	1	20	1257	4683	0.225641607994549
R-HSA-1296071	Potassium Channels	 64	0.894953819992747	1	10	54	1248	4649	0.740386526232115
R-HSA-1296072	Voltage gated Potassium channels	 29	0.763456111655678	1	5	24	1253	4679	0.816978235842333
R-HSA-1296346	Tandem pore domain potassium channels	  5	0.285442766330515	1	2	3	1256	4700	1.89538950715421
R-HSA-1358803	Downregulation of ERBB2:ERBB3 signaling	 10	0.906743192466844	1	1	9	1257	4694	0.473847376788553
R-HSA-1362277	Transcription of E2F targets under negative control by DREAM complex	 10	0.656813358899076	1	2	8	1256	4695	0.947694753577107
R-HSA-1362300	Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1	  8	0.850065813595789	1	1	7	1257	4696	0.592309220985692
R-HSA-1362409	Mitochondrial iron-sulfur cluster biogenesis	  9	0.100768114047514	1	4	5	1254	4698	2.10598834128246
R-HSA-1368071	NR1D1 (REV-ERBA) represses gene expression	  7	0.167421732949172	1	3	4	1255	4699	2.03077447195094
R-HSA-1368082	RORA activates gene expression	 23	0.354215017622652	1	6	17	1252	4686	1.23612359162231
R-HSA-1368108	BMAL1:CLOCK,NPAS2 activates circadian gene expression	 39	0.44300159299677	1	9	30	1249	4673	1.09349394643512
R-HSA-1369062	ABC transporters in lipid homeostasis	 11	0.0616765637262025	1	5	6	1253	4697	2.15385171267524
R-HSA-139853	Elevation of cytosolic Ca2+ levels	  8	0.227769868815571	1	3	5	1255	4698	1.77692766295707
R-HSA-139915	Activation of PUMA and translocation to mitochondria	  5	0.285442766330515	1	2	3	1256	4700	1.89538950715421
R-HSA-140342	Apoptosis induced DNA fragmentation	  8	0.528741782085573	1	2	6	1256	4697	1.18461844197138
R-HSA-140534	Ligand-dependent caspase activation	 11	0.709604789044377	1	2	9	1256	4694	0.861540685070097
R-HSA-140837	Intrinsic Pathway of Fibrin Clot Formation	 12	1	1	0	12	1258	4691	0
R-HSA-140875	Common Pathway of Fibrin Clot Formation	 11	0.926457032809091	1	1	10	1257	4693	0.430770342535048
R-HSA-140877	Formation of Fibrin Clot (Clotting Cascade)	 18	0.98606788331447	1	1	17	1257	4686	0.263248542660307
R-HSA-141405	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	 11	0.926457032809091	1	1	10	1257	4693	0.430770342535048
R-HSA-141424	Amplification of signal from the kinetochores	 51	0.872100240837482	1	8	43	1250	4660	0.743290002805574
R-HSA-141430	Inactivation of APC/C via direct inhibition of the APC/C complex	 11	0.926457032809091	1	1	10	1257	4693	0.430770342535048
R-HSA-141444	Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal	 51	0.872100240837482	1	8	43	1250	4660	0.743290002805574
R-HSA-1433557	Signaling by SCF-KIT	 22	0.312783404638284	1	6	16	1252	4687	1.29231102760515
R-HSA-1433559	Regulation of KIT signaling	 10	0.35569981181152	1	3	7	1255	4696	1.42154213036566
R-HSA-1442490	Collagen degradation	 32	0.11874799054408	1	10	22	1248	4681	1.48077305246423
R-HSA-1445148	Translocation of GLUT4 to the plasma membrane	 51	0.38807836443088	1	12	39	1246	4664	1.11493500420836
R-HSA-1461973	Defensins	  6	1	1	0	6	1258	4697	0
R-HSA-1474151	Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation	  8	0.528741782085573	1	2	6	1256	4697	1.18461844197138
R-HSA-1474165	Reproduction	 44	0.20240654911247	1	12	32	1246	4671	1.29231102760515
R-HSA-1474228	Degradation of the extracellular matrix	 75	0.526488523217868	1	16	59	1242	4644	1.01087440381558
R-HSA-1474290	Collagen formation	 55	0.752576935646815	1	10	45	1248	4658	0.861540685070097
R-HSA-1475029	Reversible hydration of carbon dioxide	  6	0.758985808815735	1	1	5	1257	4698	0.789745627980922
R-HSA-1480926	O2/CO2 exchange in erythrocytes	  9	0.881750209110067	1	1	8	1257	4695	0.526497085320615
R-HSA-1482788	Acyl chain remodelling of PC	 13	0.119008035120833	1	5	8	1253	4695	1.8224899107252
R-HSA-1482801	Acyl chain remodelling of PS	 11	0.709604789044377	1	2	9	1256	4694	0.861540685070097
R-HSA-1482839	Acyl chain remodelling of PE	 14	0.154445975766771	1	5	9	1253	4694	1.69231205995912
R-HSA-1482922	Acyl chain remodelling of PI	  8	0.227769868815571	1	3	5	1255	4698	1.77692766295707
R-HSA-1482925	Acyl chain remodelling of PG	  8	0.528741782085573	1	2	6	1256	4697	1.18461844197138
R-HSA-1483115	Hydrolysis of LPC	  5	0.285442766330515	1	2	3	1256	4700	1.89538950715421
R-HSA-1483148	Synthesis of PG	  8	0.528741782085573	1	2	6	1256	4697	1.18461844197138
R-HSA-1483166	Synthesis of PA	 20	0.635673802887573	1	4	16	1254	4687	0.947694753577107
R-HSA-1483191	Synthesis of PC	 20	0.109003485304835	1	7	13	1251	4690	1.65846581875994
R-HSA-1483206	Glycerophospholipid biosynthesis	 83	0.140864135569354	1	22	61	1236	4642	1.25598099871665
R-HSA-1483213	Synthesis of PE	  9	0.596590649481565	1	2	7	1256	4696	1.05299417064123
R-HSA-1483249	Inositol phosphate metabolism	 38	0.843035992116646	1	6	32	1252	4671	0.748180068613505
R-HSA-1483255	PI Metabolism	 60	0.911874895788105	1	9	51	1249	4652	0.71077106518283
R-HSA-1489509	DAG and IP3 signaling	 28	0.376365416842813	1	7	21	1251	4682	1.18461844197138
R-HSA-1500620	Meiosis	 37	0.376506851596207	1	9	28	1249	4675	1.15260172732351
R-HSA-1500931	Cell-Cell communication	 77	0.95253702674694	1	11	66	1247	4637	0.676924823983648
R-HSA-1502540	Signaling by Activin	 10	0.656813358899076	1	2	8	1256	4695	0.947694753577107
R-HSA-1538133	G0 and Early G1	 14	0.82853459821947	1	2	12	1256	4691	0.676924823983648
R-HSA-156580	Phase II - Conjugation of compounds	 42	0.540452562240588	1	9	33	1249	4670	1.01538723597547
R-HSA-156581	Methylation	  9	0.291270746199599	1	3	6	1255	4697	1.57949125596184
R-HSA-156584	Cytosolic sulfonation of small molecules	 11	0.926457032809091	1	1	10	1257	4693	0.430770342535048
R-HSA-156590	Glutathione conjugation	 20	0.418741336951152	1	5	15	1253	4688	1.18461844197138
R-HSA-1566948	Elastic fibre formation	 25	0.979665446317371	1	2	23	1256	4680	0.379077901430843
R-HSA-1566977	Fibronectin matrix formation	  5	1	1	0	5	1258	4698	0
R-HSA-156711	Polo-like kinase mediated events	  6	1	1	0	6	1258	4697	0
R-HSA-156827	L13a-mediated translational silencing of Ceruloplasmin expression	 31	0.323951773629733	1	8	23	1250	4680	1.22283194009949
R-HSA-156842	Eukaryotic Translation Elongation	 19	0.372319270008444	1	5	14	1253	4689	1.24696678102251
R-HSA-156902	Peptide chain elongation	 18	0.325876881589819	1	5	13	1253	4690	1.31624271330154
R-HSA-157118	Signaling by NOTCH	 86	0.184732885751695	1	22	64	1236	4639	1.21216770806374
R-HSA-157579	Telomere Maintenance	 30	0.904403630664436	1	4	26	1254	4677	0.631796502384738
R-HSA-157858	Gap junction trafficking and regulation	 28	0.95377919798048	1	3	25	1255	4678	0.507693617987736
R-HSA-15869	Metabolism of nucleotides	 62	0.561028044258995	1	13	49	1245	4654	0.993550951330837
R-HSA-1592230	Mitochondrial biogenesis	 69	0.817003044250816	1	12	57	1246	4646	0.824082394414875
R-HSA-159227	Transport of the SLBP independent Mature mRNA	 26	0.478712348801691	1	6	20	1252	4683	1.09349394643512
R-HSA-159230	Transport of the SLBP Dependant Mature mRNA	 27	0.518839649379423	1	6	21	1252	4682	1.05299417064123
R-HSA-159231	Transport of Mature mRNA Derived from an Intronless Transcript	 31	0.323951773629733	1	8	23	1250	4680	1.22283194009949
R-HSA-159234	Transport of Mature mRNAs Derived from Intronless Transcripts	 32	0.359035323489969	1	8	24	1250	4679	1.18461844197138
R-HSA-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript	 50	0.00454910235505511	0.423715563331436	19	31	1239	4672	1.8006200317965
R-HSA-1592389	Activation of Matrix Metalloproteinases	 13	0.954269742184979	1	1	12	1257	4691	0.364497982145041
R-HSA-159418	Recycling of bile acids and salts	  5	0.285442766330515	1	2	3	1256	4700	1.89538950715421
R-HSA-159740	Gamma-carboxylation of protein precursors	  6	0.758985808815735	1	1	5	1257	4698	0.789745627980922
R-HSA-159763	Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus	  5	0.694448590316415	1	1	4	1257	4699	0.947694753577107
R-HSA-159782	Removal of aminoterminal propeptides from gamma-carboxylated proteins	  5	0.694448590316415	1	1	4	1257	4699	0.947694753577107
R-HSA-159854	Gamma-carboxylation, transport, and amino-terminal cleavage of proteins	  6	0.758985808815735	1	1	5	1257	4698	0.789745627980922
R-HSA-1606322	ZBP1(DAI) mediated induction of type I IFNs	 19	0.592287309700289	1	4	15	1254	4688	0.997573424818007
R-HSA-1614517	Sulfide oxidation to sulfate	  5	1	1	0	5	1258	4698	0
R-HSA-1614558	Degradation of cysteine and homocysteine	  9	0.881750209110067	1	1	8	1257	4695	0.526497085320615
R-HSA-1614635	Sulfur amino acid metabolism	 17	0.497066833796374	1	4	13	1254	4690	1.11493500420836
R-HSA-162587	HIV Life Cycle	 98	0.169573663774945	1	25	73	1233	4630	1.20879432854223
R-HSA-162588	Budding and maturation of HIV virion	 17	0.280104557481713	1	5	12	1253	4691	1.39366875526045
R-HSA-162592	Integration of provirus	  8	0.528741782085573	1	2	6	1256	4697	1.18461844197138
R-HSA-162594	Early Phase of HIV Life Cycle	 11	0.709604789044377	1	2	9	1256	4694	0.861540685070097
R-HSA-162599	Late Phase of HIV Life Cycle	 88	0.150710682714176	1	23	65	1235	4638	1.23846473478826
R-HSA-162658	Golgi Cisternae Pericentriolar Stack Reorganization	  8	0.528741782085573	1	2	6	1256	4697	1.18461844197138
R-HSA-162710	Synthesis of glycosylphosphatidylinositol (GPI)	 14	0.963941676336172	1	1	13	1257	4690	0.338462411991824
R-HSA-162791	Attachment of GPI anchor to uPAR	  5	0.694448590316415	1	1	4	1257	4699	0.947694753577107
R-HSA-162909	Host Interactions of HIV factors	100	0.974543960972862	1	14	86	1244	4617	0.663386327503975
R-HSA-1630316	Glycosaminoglycan metabolism	 80	0.966371433267231	1	11	69	1247	4634	0.651540143084261
R-HSA-163125	Post-translational modification: synthesis of GPI-anchored proteins	 51	0.999427426891732	1	3	48	1255	4655	0.27873375105209
R-HSA-163200	Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.	 68	0.800753933476291	1	12	56	1246	4647	0.83620125315627
R-HSA-163210	Formation of ATP by chemiosmotic coupling	  9	0.881750209110067	1	1	8	1257	4695	0.526497085320615
R-HSA-1632852	Macroautophagy	 51	0.267872599649558	1	13	38	1245	4665	1.20784625455906
R-HSA-163359	Glucagon signaling in metabolic regulation	 25	0.805251530423266	1	4	21	1254	4682	0.758155802861685
R-HSA-163560	Triglyceride catabolism	 15	0.85715519636857	1	2	13	1256	4690	0.631796502384738
R-HSA-163615	PKA activation	 15	0.393450866625033	1	4	11	1254	4692	1.26359300476948
R-HSA-163680	AMPK inhibits chREBP transcriptional activation activity	  7	0.0399787305555638	0.895270593253458	4	3	1254	4700	2.70769929593459
R-HSA-163685	Integration of energy metabolism	 85	0.738208887849629	1	16	69	1242	4634	0.891948003366688
R-HSA-163767	PP2A-mediated dephosphorylation of key metabolic factors	  6	0.758985808815735	1	1	5	1257	4698	0.789745627980922
R-HSA-1638074	Keratan sulfate/keratin metabolism	 24	0.908530114618068	1	3	21	1255	4682	0.592309220985692
R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	 38	0.92704060053972	1	5	33	1253	4670	0.623483390511254
R-HSA-163841	Gamma carboxylation, hypusine formation and arylsulfatase activation	 21	0.464530482260742	1	5	16	1253	4687	1.12820803997275
R-HSA-1643713	Signaling by EGFR in Cancer	 15	0.642500710250324	1	3	12	1255	4691	0.947694753577107
R-HSA-164378	PKA activation in glucagon signalling	 15	0.393450866625033	1	4	11	1254	4692	1.26359300476948
R-HSA-164843	2-LTR circle formation	  6	0.371762497819815	1	2	4	1256	4699	1.57949125596184
R-HSA-164938	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	 14	0.34015887110078	1	4	10	1254	4693	1.3538496479673
R-HSA-164940	Nef mediated downregulation of MHC class I complex cell surface expression	  6	0.112803303351911	1	3	3	1255	4700	2.36923688394277
R-HSA-164944	Nef and signal transduction	  5	1	1	0	5	1258	4698	0
R-HSA-164952	The role of Nef in HIV-1 replication and disease pathogenesis	 19	0.592287309700289	1	4	15	1254	4688	0.997573424818007
R-HSA-165054	Rev-mediated nuclear export of HIV RNA	 27	0.702858098745796	1	5	22	1253	4681	0.877495142201025
R-HSA-1650814	Collagen biosynthesis and modifying enzymes	 42	0.904377902946159	1	6	36	1252	4667	0.676924823983648
R-HSA-165159	mTOR signalling	 29	0.256104004986529	1	8	21	1250	4682	1.30716517734773
R-HSA-1655829	Regulation of cholesterol biosynthesis by SREBP (SREBF)	 42	0.0876972825069813	1	13	29	1245	4674	1.46667045196457
R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	 89	0.622977111324729	1	18	71	1240	4632	0.958343009235276
R-HSA-1660499	Synthesis of PIPs at the plasma membrane	 40	0.945337830578547	1	5	35	1253	4668	0.592309220985692
R-HSA-1660514	Synthesis of PIPs at the Golgi membrane	 11	0.186227514654976	1	4	7	1254	4696	1.72308137014019
R-HSA-1660516	Synthesis of PIPs at the early endosome membrane	 15	0.393450866625033	1	4	11	1254	4692	1.26359300476948
R-HSA-1660517	Synthesis of PIPs at the late endosome membrane	 10	0.656813358899076	1	2	8	1256	4695	0.947694753577107
R-HSA-166054	Activated TLR4 signalling	 82	0.577125483271744	1	17	65	1241	4638	0.982366512854318
R-HSA-166058	MyD88:Mal cascade initiated on plasma membrane	 69	0.817003044250816	1	12	57	1246	4646	0.824082394414875
R-HSA-1660661	Sphingolipid de novo biosynthesis	 31	0.490255091512387	1	7	24	1251	4679	1.06997794758706
R-HSA-1660662	Glycosphingolipid metabolism	 28	0.734415020592046	1	5	23	1253	4680	0.846156029979559
R-HSA-166166	MyD88-independent TLR4 cascade 	 75	0.414076460512097	1	17	58	1241	4645	1.07405405405405
R-HSA-166208	mTORC1-mediated signalling	 16	0.687843131132348	1	3	13	1255	4690	0.888463831478537
R-HSA-1663150	The activation of arylsulfatases	  5	0.694448590316415	1	1	4	1257	4699	0.947694753577107
R-HSA-166658	Complement cascade	 28	0.95377919798048	1	3	25	1255	4678	0.507693617987736
R-HSA-166663	Initial triggering of complement	 16	1	1	0	16	1258	4687	0
R-HSA-166786	Creation of C4 and C2 activators	 12	1	1	0	12	1258	4691	0
R-HSA-167044	Signalling to RAS	 17	0.901691816657284	1	2	15	1256	4688	0.55746750210418
R-HSA-167152	Formation of HIV elongation complex in the absence of HIV Tat	 25	0.0626604489141934	1	9	16	1249	4687	1.70585055643879
R-HSA-167158	Formation of the HIV-1 Early Elongation Complex	 19	0.0312926420674363	0.832120089163637	8	11	1250	4692	1.99514684963601
R-HSA-167160	RNA Pol II CTD phosphorylation and interaction with CE during HIV infection	 15	0.193605883409086	1	5	10	1253	4693	1.57949125596184
R-HSA-167161	HIV Transcription Initiation	 31	0.323951773629733	1	8	23	1250	4680	1.22283194009949
R-HSA-167162	RNA Polymerase II HIV Promoter Escape	 31	0.323951773629733	1	8	23	1250	4680	1.22283194009949
R-HSA-167169	HIV Transcription Elongation	 24	0.114068952130215	1	8	16	1250	4687	1.57949125596184
R-HSA-167172	Transcription of the HIV genome	 43	0.179588689232901	1	12	31	1246	4672	1.32236477243317
R-HSA-167200	Formation of HIV-1 elongation complex containing HIV-1 Tat	 24	0.114068952130215	1	8	16	1250	4687	1.57949125596184
R-HSA-167238	Pausing and recovery of Tat-mediated HIV elongation	 16	0.687843131132348	1	3	13	1255	4690	0.888463831478537
R-HSA-167242	Abortive elongation of HIV-1 transcript in the absence of Tat	 13	0.287098043862492	1	4	9	1254	4694	1.45799192858016
R-HSA-167243	Tat-mediated HIV elongation arrest and recovery	 16	0.687843131132348	1	3	13	1255	4690	0.888463831478537
R-HSA-167246	Tat-mediated elongation of the HIV-1 transcript	 24	0.114068952130215	1	8	16	1250	4687	1.57949125596184
R-HSA-167287	HIV elongation arrest and recovery	 17	0.497066833796374	1	4	13	1254	4690	1.11493500420836
R-HSA-167290	Pausing and recovery of HIV elongation	 17	0.497066833796374	1	4	13	1254	4690	1.11493500420836
R-HSA-167590	Nef Mediated CD4 Down-regulation	  8	0.850065813595789	1	1	7	1257	4696	0.592309220985692
R-HSA-1679131	Trafficking and processing of endosomal TLR	  8	0.227769868815571	1	3	5	1255	4698	1.77692766295707
R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade	 71	0.846505612477413	1	12	59	1246	4644	0.800868805839808
R-HSA-168142	Toll Like Receptor 10 (TLR10) Cascade	 63	0.805252904474666	1	11	52	1247	4651	0.82735256264668
R-HSA-168164	Toll Like Receptor 3 (TLR3) Cascade	 74	0.502507283173971	1	16	58	1242	4645	1.02453486873201
R-HSA-168176	Toll Like Receptor 5 (TLR5) Cascade	 63	0.805252904474666	1	11	52	1247	4651	0.82735256264668
R-HSA-168179	Toll Like Receptor TLR1:TLR2 Cascade	 69	0.817003044250816	1	12	57	1246	4646	0.824082394414875
R-HSA-168180	TRAF6 Mediated Induction of proinflammatory cytokines	 63	0.704056871387711	1	12	51	1246	4652	0.902566431978197
R-HSA-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	 68	0.800753933476291	1	12	56	1246	4647	0.83620125315627
R-HSA-168188	Toll Like Receptor TLR6:TLR2 Cascade	 69	0.817003044250816	1	12	57	1246	4646	0.824082394414875
R-HSA-168253	Host Interactions with Influenza Factors	 30	0.452702729409852	1	7	23	1251	4680	1.10564387917329
R-HSA-168254	Influenza Infection	 65	0.514899433146859	1	14	51	1244	4652	1.02059435000611
R-HSA-168255	Influenza Life Cycle	 58	0.583031961740281	1	12	46	1246	4657	0.9803738830108
R-HSA-168271	Transport of Ribonucleoproteins into the Host Nucleus	 23	0.552202797361461	1	5	18	1253	4685	1.03010299301859
R-HSA-168273	Influenza Viral RNA Transcription and Replication	 50	0.493864427347073	1	11	39	1247	4664	1.04246422893482
R-HSA-168274	Export of Viral Ribonucleoproteins from Nucleus	 25	0.632229019791489	1	5	20	1253	4683	0.947694753577107
R-HSA-168276	 NS1 Mediated Effects on Host Pathways	 28	0.376365416842813	1	7	21	1251	4682	1.18461844197138
R-HSA-168325	Viral Messenger RNA Synthesis	 30	0.630596547005804	1	6	24	1252	4679	0.947694753577107
R-HSA-168333	NEP/NS2 Interacts with the Cellular Export Machinery	 24	0.593310593184808	1	5	19	1253	4684	0.987182034976153
R-HSA-168638	NOD1/2 Signaling Pathway	 20	0.635673802887573	1	4	16	1254	4687	0.947694753577107
R-HSA-168643	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	 31	0.814210626174389	1	5	26	1253	4677	0.764269962562183
R-HSA-168799	Neurotoxicity of clostridium toxins	 10	0.906743192466844	1	1	9	1257	4694	0.473847376788553
R-HSA-168927	TICAM1, RIP1-mediated IKK complex recruitment 	 11	0.419251923245224	1	3	8	1255	4695	1.29231102760515
R-HSA-168928	DDX58/IFIH1-mediated induction of interferon-alpha/beta	 53	0.7077798048714	1	10	43	1248	4660	0.894051654318025
R-HSA-169893	Prolonged ERK activation events	 11	0.709604789044377	1	2	9	1256	4694	0.861540685070097
R-HSA-169911	Regulation of Apoptosis	 40	0.994959084400153	1	3	37	1255	4666	0.355385532591415
R-HSA-170660	Adenylate cyclase activating pathway	 10	0.906743192466844	1	1	9	1257	4694	0.473847376788553
R-HSA-170670	Adenylate cyclase inhibitory pathway	 13	0.794842618691727	1	2	11	1256	4692	0.728995964290082
R-HSA-170822	Regulation of Glucokinase by Glucokinase Regulatory Protein	 23	0.552202797361461	1	5	18	1253	4685	1.03010299301859
R-HSA-170834	Signaling by TGF-beta Receptor Complex	 56	0.658088613710923	1	11	45	1247	4658	0.930771632977515
R-HSA-170968	Frs2-mediated activation	  9	0.881750209110067	1	1	8	1257	4695	0.526497085320615
R-HSA-170984	ARMS-mediated activation	  7	0.809900309657012	1	1	6	1257	4697	0.676924823983648
R-HSA-171007	p38MAPK events	 10	1	1	0	10	1258	4693	0
R-HSA-171306	Packaging Of Telomere Ends	 13	0.794842618691727	1	2	11	1256	4692	0.728995964290082
R-HSA-173623	Classical antibody-mediated complement activation	  8	1	1	0	8	1258	4695	0
R-HSA-174048	APC/C:Cdc20 mediated degradation of Cyclin B	 11	0.926457032809091	1	1	10	1257	4693	0.430770342535048
R-HSA-174084	Autodegradation of Cdh1 by Cdh1:APC/C	 45	0.998099621822689	1	3	42	1255	4661	0.315898251192369
R-HSA-174113	SCF-beta-TrCP mediated degradation of Emi1	 40	0.994959084400153	1	3	37	1255	4666	0.355385532591415
R-HSA-174143	APC/C-mediated degradation of cell cycle proteins	 56	0.995775150373934	1	5	51	1253	4652	0.42307801498978
R-HSA-174154	APC/C:Cdc20 mediated degradation of Securin	 47	0.994318807696859	1	4	43	1254	4660	0.403274363224301
R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	 48	0.984040710984609	1	5	43	1253	4660	0.493591017488076
R-HSA-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A	 50	0.996697554552531	1	4	46	1254	4657	0.379077901430843
R-HSA-174403	Glutathione synthesis and recycling	  9	0.100768114047514	1	4	5	1254	4698	2.10598834128246
R-HSA-174411	Polymerase switching on the C-strand of the telomere	  9	0.596590649481565	1	2	7	1256	4696	1.05299417064123
R-HSA-174414	Processive synthesis on the C-strand of the telomere	  7	1	1	0	7	1258	4696	0
R-HSA-174417	Telomere C-strand (Lagging Strand) Synthesis	 16	0.881342634259459	1	2	14	1256	4689	0.592309220985692
R-HSA-174437	Removal of the Flap Intermediate from the C-strand	  7	1	1	0	7	1258	4696	0
R-HSA-174490	Membrane binding and targetting of GAG proteins	  7	0.453498803768073	1	2	5	1256	4698	1.3538496479673
R-HSA-174495	Synthesis And Processing Of GAG, GAGPOL Polyproteins	  7	0.453498803768073	1	2	5	1256	4698	1.3538496479673
R-HSA-174824	Plasma lipoprotein assembly, remodeling, and clearance	 39	0.860807015981936	1	6	33	1252	4670	0.728995964290082
R-HSA-175474	Assembly Of The HIV Virion	  8	0.528741782085573	1	2	6	1256	4697	1.18461844197138
R-HSA-176033	Interactions of Vpr with host cellular proteins	 29	0.595017783486614	1	6	23	1252	4680	0.9803738830108
R-HSA-176187	Activation of ATR in response to replication stress	 22	0.962823796383355	1	2	20	1256	4683	0.430770342535048
R-HSA-176407	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	  9	0.881750209110067	1	1	8	1257	4695	0.526497085320615
R-HSA-176408	Regulation of APC/C activators between G1/S and early anaphase	 54	0.998421695003395	1	4	50	1254	4653	0.35099805688041
R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	 52	0.997712345673983	1	4	48	1254	4655	0.364497982145041
R-HSA-176412	Phosphorylation of the APC/C	 10	0.906743192466844	1	1	9	1257	4694	0.473847376788553
R-HSA-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	 52	0.997712345673983	1	4	48	1254	4655	0.364497982145041
R-HSA-176974	Unwinding of DNA	  6	1	1	0	6	1258	4697	0
R-HSA-177243	Interactions of Rev with host cellular proteins	 28	0.734415020592046	1	5	23	1253	4680	0.846156029979559
R-HSA-177504	Retrograde neurotrophin signalling	 13	0.954269742184979	1	1	12	1257	4691	0.364497982145041
R-HSA-177929	Signaling by EGFR	 34	0.016645787392561	0.600124440205488	13	21	1245	4682	1.81176938183859
R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	 34	0.984332038535655	1	3	31	1255	4672	0.418100626578135
R-HSA-179409	APC-Cdc20 mediated degradation of Nek2A	 12	0.942006117300883	1	1	11	1257	4692	0.394872813990461
R-HSA-179419	APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint	 50	0.996697554552531	1	4	46	1254	4657	0.379077901430843
R-HSA-179812	GRB2 events in EGFR signaling	  6	0.758985808815735	1	1	5	1257	4698	0.789745627980922
R-HSA-1799339	SRP-dependent cotranslational protein targeting to membrane	 36	0.00411854372452668	0.423715563331436	15	21	1243	4682	1.97436406995231
R-HSA-180024	DARPP-32 events	 22	0.164036518152948	1	7	15	1251	4688	1.50769619887267
R-HSA-180292	GAB1 signalosome	  8	0.227769868815571	1	3	5	1255	4698	1.77692766295707
R-HSA-180336	SHC1 events in EGFR signaling	  7	0.809900309657012	1	1	6	1257	4697	0.676924823983648
R-HSA-180534	Vpu mediated degradation of CD4	 40	0.994959084400153	1	3	37	1255	4666	0.355385532591415
R-HSA-180585	Vif-mediated degradation of APOBEC3G	 41	0.983746281254152	1	4	37	1254	4666	0.462290123696149
R-HSA-180746	Nuclear import of Rev protein	 25	0.632229019791489	1	5	20	1253	4683	0.947694753577107
R-HSA-180786	Extension of Telomeres	 17	0.901691816657284	1	2	15	1256	4688	0.55746750210418
R-HSA-180910	Vpr-mediated nuclear import of PICs	 26	0.478712348801691	1	6	20	1252	4683	1.09349394643512
R-HSA-1810476	RIP-mediated NFkB activation via ZBP1	 16	0.687843131132348	1	3	13	1255	4690	0.888463831478537
R-HSA-181429	Serotonin Neurotransmitter Release Cycle	 15	0.642500710250324	1	3	12	1255	4691	0.947694753577107
R-HSA-181430	Norepinephrine Neurotransmitter Release Cycle	 16	0.687843131132348	1	3	13	1255	4690	0.888463831478537
R-HSA-181438	Toll Like Receptor 2 (TLR2) Cascade	 69	0.817003044250816	1	12	57	1246	4646	0.824082394414875
R-HSA-182218	Nef Mediated CD8 Down-regulation	  6	0.758985808815735	1	1	5	1257	4698	0.789745627980922
R-HSA-182971	EGFR downregulation	 19	0.195838194017673	1	6	13	1252	4690	1.49636013722701
R-HSA-1834941	STING mediated induction of host immune responses	 10	0.906743192466844	1	1	9	1257	4694	0.473847376788553
R-HSA-1834949	Cytosolic sensors of pathogen-associated DNA 	 49	0.734533457862184	1	9	40	1249	4663	0.870331916550404
R-HSA-1839117	Signaling by cytosolic FGFR1 fusion mutants	 15	0.193605883409086	1	5	10	1253	4693	1.57949125596184
R-HSA-1839124	FGFR1 mutant receptor activation	 21	0.056719331454607	1	8	13	1250	4690	1.80513286395639
R-HSA-1839126	FGFR2 mutant receptor activation	 14	0.154445975766771	1	5	9	1253	4694	1.69231205995912
R-HSA-1855167	Synthesis of pyrophosphates in the cytosol	  9	0.881750209110067	1	1	8	1257	4695	0.526497085320615
R-HSA-1855183	Synthesis of IP2, IP, and Ins in the cytosol	 12	0.755417103399376	1	2	10	1256	4693	0.789745627980922
R-HSA-1855204	Synthesis of IP3 and IP4 in the cytosol	 19	0.932983775923062	1	2	17	1256	4686	0.498786712409003
R-HSA-186712	Regulation of beta-cell development	 13	0.954269742184979	1	1	12	1257	4691	0.364497982145041
R-HSA-186763	Downstream signal transduction	 21	0.851361715004481	1	3	18	1255	4685	0.676924823983648
R-HSA-186797	Signaling by PDGF	 40	0.876881854453564	1	6	34	1252	4669	0.71077106518283
R-HSA-187015	Activation of TRKA receptors	  5	1	1	0	5	1258	4698	0
R-HSA-187037	NGF signalling via TRKA from the plasma membrane	 69	0.817003044250816	1	12	57	1246	4646	0.824082394414875
R-HSA-187577	SCF(Skp2)-mediated degradation of p27/p21	 45	0.998099621822689	1	3	42	1255	4661	0.315898251192369
R-HSA-187687	Signalling to ERKs	 28	0.871815972171414	1	4	24	1254	4679	0.676924823983648
R-HSA-187706	Signalling to p38 via RIT and RIN	  5	1	1	0	5	1258	4698	0
R-HSA-189200	Cellular hexose transport	  8	0.528741782085573	1	2	6	1256	4697	1.18461844197138
R-HSA-189445	Metabolism of porphyrins	 10	0.906743192466844	1	1	9	1257	4694	0.473847376788553
R-HSA-189451	Heme biosynthesis	  8	0.850065813595789	1	1	7	1257	4696	0.592309220985692
R-HSA-190236	Signaling by FGFR	 51	0.0134008843819025	0.578684096835011	18	33	1240	4670	1.67240250631254
R-HSA-190241	FGFR2 ligand binding and activation	  5	0.0666681617559274	1	3	2	1255	4701	2.84308426073132
R-HSA-190242	FGFR1 ligand binding and activation	  5	0.00821657627503388	0.423715563331436	4	1	1254	4702	3.79077901430843
R-HSA-190373	FGFR1c ligand binding and activation	  5	0.00821657627503388	0.423715563331436	4	1	1254	4702	3.79077901430843
R-HSA-190828	Gap junction trafficking	 27	0.944997423786652	1	3	24	1255	4679	0.526497085320615
R-HSA-190840	Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane	 10	1	1	0	10	1258	4693	0
R-HSA-190861	Gap junction assembly	 18	0.98606788331447	1	1	17	1257	4686	0.263248542660307
R-HSA-190872	Transport of connexons to the plasma membrane	 11	1	1	0	11	1258	4692	0
R-HSA-190873	Gap junction degradation	 10	0.656813358899076	1	2	8	1256	4695	0.947694753577107
R-HSA-1912399	Pre-NOTCH Processing in the Endoplasmic Reticulum	  5	1	1	0	5	1258	4698	0
R-HSA-1912408	Pre-NOTCH Transcription and Translation	 22	0.0732363709663838	1	8	14	1250	4689	1.72308137014019
R-HSA-1912420	Pre-NOTCH Processing in Golgi	 13	0.794842618691727	1	2	11	1256	4692	0.728995964290082
R-HSA-1912422	Pre-NOTCH Expression and Processing	 32	0.11874799054408	1	10	22	1248	4681	1.48077305246423
R-HSA-191273	Cholesterol biosynthesis	 20	0.418741336951152	1	5	15	1253	4688	1.18461844197138
R-HSA-191859	snRNP Assembly	 35	0.465242092389856	1	8	27	1250	4676	1.08307971837384
R-HSA-192105	Synthesis of bile acids and bile salts	 18	0.161096514800637	1	6	12	1252	4691	1.57949125596184
R-HSA-192823	Viral mRNA Translation	 18	0.325876881589819	1	5	13	1253	4690	1.31624271330154
R-HSA-193048	Androgen biosynthesis	  6	0.371762497819815	1	2	4	1256	4699	1.57949125596184
R-HSA-193368	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	 11	0.186227514654976	1	4	7	1254	4696	1.72308137014019
R-HSA-193634	Axonal growth inhibition (RHOA activation)	  9	0.596590649481565	1	2	7	1256	4696	1.05299417064123
R-HSA-193639	p75NTR signals via NF-kB	 12	0.942006117300883	1	1	11	1257	4692	0.394872813990461
R-HSA-193648	NRAGE signals death through JNK	 38	0.56726627761331	1	8	30	1250	4673	0.997573424818007
R-HSA-193670	p75NTR negatively regulates cell cycle via SC1	  6	0.758985808815735	1	1	5	1257	4698	0.789745627980922
R-HSA-193692	Regulated proteolysis of p75NTR	  8	0.227769868815571	1	3	5	1255	4698	1.77692766295707
R-HSA-193697	p75NTR regulates axonogenesis	 10	0.656813358899076	1	2	8	1256	4695	0.947694753577107
R-HSA-193704	p75 NTR receptor-mediated signalling	 69	0.496037716749381	1	15	54	1243	4649	1.03010299301859
R-HSA-193807	Synthesis of bile acids and bile salts via 27-hydroxycholesterol	  7	0.453498803768073	1	2	5	1256	4698	1.3538496479673
R-HSA-194068	Bile acid and bile salt metabolism	 20	0.109003485304835	1	7	13	1251	4690	1.65846581875994
R-HSA-194138	Signaling by VEGF	 79	0.929197459482007	1	12	67	1246	4636	0.719768167273752
R-HSA-194313	VEGF ligand-receptor interactions	  6	0.758985808815735	1	1	5	1257	4698	0.789745627980922
R-HSA-194441	Metabolism of non-coding RNA	 35	0.465242092389856	1	8	27	1250	4676	1.08307971837384
R-HSA-194840	Rho GTPase cycle	 94	0.174439034514663	1	24	70	1234	4633	1.2098230896729
R-HSA-195253	Degradation of beta-catenin by the destruction complex	 70	0.97357406595866	1	9	61	1249	4642	0.609232341585283
R-HSA-195399	VEGF binds to VEGFR leading to receptor dimerization	  6	0.758985808815735	1	1	5	1257	4698	0.789745627980922
R-HSA-196025	Formation of annular gap junctions	  9	0.881750209110067	1	1	8	1257	4695	0.526497085320615
R-HSA-196071	Metabolism of steroid hormones	 18	0.545978248712532	1	4	14	1254	4689	1.05299417064123
R-HSA-196108	Pregnenolone biosynthesis	  7	0.809900309657012	1	1	6	1257	4697	0.676924823983648
R-HSA-196299	Beta-catenin phosphorylation cascade	 16	0.100882651035028	1	6	10	1252	4693	1.77692766295707
R-HSA-1963640	GRB2 events in ERBB2 signaling	 12	0.755417103399376	1	2	10	1256	4693	0.789745627980922
R-HSA-1963642	PI3K events in ERBB2 signaling	 12	0.480543217269381	1	3	9	1255	4694	1.18461844197138
R-HSA-196741	Cobalamin (Cbl, vitamin B12) transport and metabolism	 12	0.235378041172751	1	4	8	1254	4695	1.57949125596184
R-HSA-196757	Metabolism of folate and pterines	 10	0.35569981181152	1	3	7	1255	4696	1.42154213036566
R-HSA-196780	Biotin transport and metabolism	  7	0.453498803768073	1	2	5	1256	4698	1.3538496479673
R-HSA-196783	Coenzyme A biosynthesis	  6	1	1	0	6	1258	4697	0
R-HSA-196807	Nicotinate metabolism	 19	0.0858228764970588	1	7	12	1251	4691	1.74575349343151
R-HSA-196836	Vitamin C (ascorbate) metabolism	  6	0.758985808815735	1	1	5	1257	4698	0.789745627980922
R-HSA-196849	Metabolism of water-soluble vitamins and cofactors	 74	0.0839807597964146	1	21	53	1237	4650	1.34470201521076
R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	 18	0.918744185015892	1	2	16	1256	4687	0.526497085320615
R-HSA-197264	Nicotinamide salvaging	 12	0.235378041172751	1	4	8	1254	4695	1.57949125596184
R-HSA-1980143	Signaling by NOTCH1	 61	0.410546131888315	1	14	47	1244	4656	1.08751856967865
R-HSA-1980145	Signaling by NOTCH2	 22	0.509161975679111	1	5	17	1253	4686	1.07692585633762
R-HSA-1980148	Signaling by NOTCH3	 10	0.140936259771786	1	4	6	1254	4697	1.89538950715421
R-HSA-1980150	Signaling by NOTCH4	 10	0.140936259771786	1	4	6	1254	4697	1.89538950715421
R-HSA-198203	PI3K/AKT activation	  8	0.528741782085573	1	2	6	1256	4697	1.18461844197138
R-HSA-198323	AKT phosphorylates targets in the cytosol	 11	1	1	0	11	1258	4692	0
R-HSA-198693	AKT phosphorylates targets in the nucleus	  8	0.850065813595789	1	1	7	1257	4696	0.592309220985692
R-HSA-198725	Nuclear Events (kinase and transcription factor activation)	 22	0.509161975679111	1	5	17	1253	4686	1.07692585633762
R-HSA-198753	ERK/MAPK targets	 19	0.592287309700289	1	4	15	1254	4688	0.997573424818007
R-HSA-198933	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	 52	0.999995822723141	1	1	51	1257	4652	0.0911244955362602
R-HSA-1989781	PPARA activates gene expression	 83	0.289396523206893	1	20	63	1238	4640	1.14180090792422
R-HSA-199220	Vitamin B5 (pantothenate) metabolism	 12	0.942006117300883	1	1	11	1257	4692	0.394872813990461
R-HSA-199418	Negative regulation of the PI3K/AKT network	 61	0.410546131888315	1	14	47	1244	4656	1.08751856967865
R-HSA-199920	CREB phosphorylation	  7	0.809900309657012	1	1	6	1257	4697	0.676924823983648
R-HSA-199992	trans-Golgi Network Vesicle Budding	 52	0.0655765238993941	1	16	36	1242	4667	1.45799192858016
R-HSA-200425	Import of palmitoyl-CoA into the mitochondrial matrix	 11	0.709604789044377	1	2	9	1256	4694	0.861540685070097
R-HSA-201451	Signaling by BMP	 20	0.418741336951152	1	5	15	1253	4688	1.18461844197138
R-HSA-201688	WNT mediated activation of DVL	  5	0.694448590316415	1	1	4	1257	4699	0.947694753577107
R-HSA-201722	Formation of the beta-catenin:TCF transactivating complex	 34	0.7531124614488	1	6	28	1252	4675	0.83620125315627
R-HSA-202040	G-protein activation	 19	0.989017000391771	1	1	18	1257	4685	0.249393356204502
R-HSA-202131	Metabolism of nitric oxide	 16	0.446016886428218	1	4	12	1254	4691	1.18461844197138
R-HSA-2022090	Assembly of collagen fibrils and other multimeric structures	 35	0.465242092389856	1	8	27	1250	4676	1.08307971837384
R-HSA-2022377	Metabolism of Angiotensinogen to Angiotensins	  7	1	1	0	7	1258	4696	0
R-HSA-2022854	Keratan sulfate biosynthesis	 20	0.826301872790362	1	3	17	1255	4686	0.71077106518283
R-HSA-2022857	Keratan sulfate degradation	  8	0.850065813595789	1	1	7	1257	4696	0.592309220985692
R-HSA-2022870	Chondroitin sulfate biosynthesis	 15	0.85715519636857	1	2	13	1256	4690	0.631796502384738
R-HSA-2022923	Dermatan sulfate biosynthesis	 11	0.926457032809091	1	1	10	1257	4693	0.430770342535048
R-HSA-2022928	HS-GAG biosynthesis	 19	0.797707662304944	1	3	16	1255	4687	0.748180068613505
R-HSA-202403	TCR signaling	 78	0.92155116584422	1	12	66	1246	4637	0.728995964290082
R-HSA-2024096	HS-GAG degradation	 15	0.85715519636857	1	2	13	1256	4690	0.631796502384738
R-HSA-2024101	CS/DS degradation	 11	0.926457032809091	1	1	10	1257	4693	0.430770342535048
R-HSA-202424	Downstream TCR signaling	 66	0.915030279093002	1	10	56	1248	4647	0.717950570891747
R-HSA-202427	Phosphorylation of CD3 and TCR zeta chains	 10	0.906743192466844	1	1	9	1257	4694	0.473847376788553
R-HSA-202430	Translocation of ZAP-70 to Immunological synapse	  7	1	1	0	7	1258	4696	0
R-HSA-202433	Generation of second messenger molecules	 16	0.977584391900723	1	1	15	1257	4688	0.296154610492846
R-HSA-2025928	Calcineurin activates NFAT	  8	0.528741782085573	1	2	6	1256	4697	1.18461844197138
R-HSA-202670	ERKs are inactivated	 11	0.419251923245224	1	3	8	1255	4695	1.29231102760515
R-HSA-202733	Cell surface interactions at the vascular wall	 86	0.966897571541412	1	12	74	1246	4629	0.661182386216586
R-HSA-2028269	Signaling by Hippo	 16	0.977584391900723	1	1	15	1257	4688	0.296154610492846
R-HSA-2029480	Fcgamma receptor (FCGR) dependent phagocytosis	 68	0.800753933476291	1	12	56	1246	4647	0.83620125315627
R-HSA-2029481	FCGR activation	  8	0.850065813595789	1	1	7	1257	4696	0.592309220985692
R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation	 47	0.685263303442875	1	9	38	1249	4665	0.907367317254677
R-HSA-2029485	Role of phospholipids in phagocytosis	 19	0.932983775923062	1	2	17	1256	4686	0.498786712409003
R-HSA-2032785	YAP1- and WWTR1 (TAZ)-stimulated gene expression	 21	0.67594281950565	1	4	17	1254	4686	0.902566431978197
R-HSA-203615	eNOS activation	  9	0.596590649481565	1	2	7	1256	4696	1.05299417064123
R-HSA-203765	eNOS activation and regulation	 16	0.446016886428218	1	4	12	1254	4691	1.18461844197138
R-HSA-203927	MicroRNA (miRNA) biogenesis	 16	0.446016886428218	1	4	12	1254	4691	1.18461844197138
R-HSA-204005	COPII (Coat Protein 2) Mediated Vesicle Transport	 52	0.551506862733625	1	11	41	1247	4662	1.00236945089886
R-HSA-204174	Regulation of pyruvate dehydrogenase (PDH) complex	 14	0.82853459821947	1	2	12	1256	4691	0.676924823983648
R-HSA-2046104	alpha-linolenic (omega3) and linoleic (omega6) acid metabolism	 10	0.140936259771786	1	4	6	1254	4697	1.89538950715421
R-HSA-2046105	Linoleic acid (LA) metabolism	  6	0.371762497819815	1	2	4	1256	4699	1.57949125596184
R-HSA-2046106	alpha-linolenic acid (ALA) metabolism	 10	0.140936259771786	1	4	6	1254	4697	1.89538950715421
R-HSA-204998	Cell death signalling via NRAGE, NRIF and NADE	 49	0.604093843963638	1	10	39	1248	4664	0.967035462833782
R-HSA-205025	NADE modulates death signalling	  6	1	1	0	6	1258	4697	0
R-HSA-205043	NRIF signals cell death from the nucleus	 10	0.656813358899076	1	2	8	1256	4695	0.947694753577107
R-HSA-209543	p75NTR recruits signalling complexes	  9	0.881750209110067	1	1	8	1257	4695	0.526497085320615
R-HSA-209560	NF-kB is activated and signals survival	  9	0.881750209110067	1	1	8	1257	4695	0.526497085320615
R-HSA-209952	Peptide hormone biosynthesis	  5	1	1	0	5	1258	4698	0
R-HSA-210500	Glutamate Neurotransmitter Release Cycle	 21	0.851361715004481	1	3	18	1255	4685	0.676924823983648
R-HSA-210745	Regulation of gene expression in beta cells	  9	0.881750209110067	1	1	8	1257	4695	0.526497085320615
R-HSA-210990	PECAM1 interactions	  7	0.167421732949172	1	3	4	1255	4699	2.03077447195094
R-HSA-210991	Basigin interactions	 18	0.545978248712532	1	4	14	1254	4689	1.05299417064123
R-HSA-210993	Tie2 Signaling	 13	0.538576769291448	1	3	10	1255	4693	1.09349394643512
R-HSA-211000	Gene Silencing by RNA	 62	0.221097518529558	1	16	46	1242	4657	1.22283194009949
R-HSA-211227	Activation of DNA fragmentation factor	  8	0.528741782085573	1	2	6	1256	4697	1.18461844197138
R-HSA-211733	Regulation of activated PAK-2p34 by proteasome mediated degradation	 38	0.9926072579238	1	3	35	1255	4668	0.374090034306753
R-HSA-211859	Biological oxidations	 87	0.944543839272182	1	13	74	1245	4629	0.708047804396689
R-HSA-211897	Cytochrome P450 - arranged by substrate type	 23	0.892159841381082	1	3	20	1255	4683	0.618061795811156
R-HSA-211945	Phase I - Functionalization of compounds	 45	0.991891775658168	1	4	41	1254	4662	0.421197668256492
R-HSA-211976	Endogenous sterols	 12	0.480543217269381	1	3	9	1255	4694	1.18461844197138
R-HSA-211981	Xenobiotics	  6	1	1	0	6	1258	4697	0
R-HSA-212165	Epigenetic regulation of gene expression	 68	0.255024970744043	1	17	51	1241	4652	1.18461844197138
R-HSA-2122947	NOTCH1 Intracellular Domain Regulates Transcription	 39	0.860807015981936	1	6	33	1252	4670	0.728995964290082
R-HSA-2122948	Activated NOTCH1 Transmits Signal to the Nucleus	 24	0.114068952130215	1	8	16	1250	4687	1.57949125596184
R-HSA-212300	PRC2 methylates histones and DNA	 17	0.728723766275771	1	3	14	1255	4689	0.83620125315627
R-HSA-212676	Dopamine Neurotransmitter Release Cycle	 18	0.545978248712532	1	4	14	1254	4689	1.05299417064123
R-HSA-2129379	Molecules associated with elastic fibres	 21	0.954676858158858	1	2	19	1256	4684	0.451283215989098
R-HSA-2132295	MHC class II antigen presentation	 79	0.96222271028485	1	11	68	1247	4635	0.659787486667606
R-HSA-2142691	Synthesis of Leukotrienes (LT) and Eoxins (EX)	  7	0.809900309657012	1	1	6	1257	4697	0.676924823983648
R-HSA-2142753	Arachidonic acid metabolism	 24	0.97510129524537	1	2	22	1256	4681	0.394872813990461
R-HSA-2142789	Ubiquinol biosynthesis	  6	1	1	0	6	1258	4697	0
R-HSA-2142845	Hyaluronan metabolism	  8	0.528741782085573	1	2	6	1256	4697	1.18461844197138
R-HSA-2151201	Transcriptional activation of mitochondrial biogenesis	 45	0.76272208455203	1	8	37	1250	4666	0.842395336512983
R-HSA-2151209	Activation of PPARGC1A (PGC-1alpha) by phosphorylation	  8	0.528741782085573	1	2	6	1256	4697	1.18461844197138
R-HSA-216083	Integrin cell surface interactions	 53	0.7077798048714	1	10	43	1248	4660	0.894051654318025
R-HSA-2160916	Hyaluronan uptake and degradation	  6	0.758985808815735	1	1	5	1257	4698	0.789745627980922
R-HSA-2161522	Abacavir transport and metabolism	  5	1	1	0	5	1258	4698	0
R-HSA-2162123	Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	  8	0.850065813595789	1	1	7	1257	4696	0.592309220985692
R-HSA-2168880	Scavenging of heme from plasma	  8	1	1	0	8	1258	4695	0
R-HSA-2172127	DAP12 interactions	 15	0.85715519636857	1	2	13	1256	4690	0.631796502384738
R-HSA-2173782	Binding and Uptake of Ligands by Scavenger Receptors	 28	0.98900310510335	1	2	26	1256	4677	0.338462411991824
R-HSA-2173788	Downregulation of TGF-beta receptor signaling	 21	0.851361715004481	1	3	18	1255	4685	0.676924823983648
R-HSA-2173789	TGF-beta receptor signaling activates SMADs	 25	0.632229019791489	1	5	20	1253	4683	0.947694753577107
R-HSA-2173791	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	 11	1	1	0	11	1258	4692	0
R-HSA-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	 32	0.218701124049026	1	9	23	1249	4680	1.33269574721781
R-HSA-2173795	Downregulation of SMAD2/3:SMAD4 transcriptional activity	 17	0.129308606576508	1	6	11	1252	4692	1.67240250631254
R-HSA-2173796	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	 22	0.509161975679111	1	5	17	1253	4686	1.07692585633762
R-HSA-2179392	EGFR Transactivation by Gastrin	  7	0.453498803768073	1	2	5	1256	4698	1.3538496479673
R-HSA-2187338	Visual phototransduction	 46	0.658636413302525	1	9	37	1249	4666	0.927092693716735
R-HSA-2197563	NOTCH2 intracellular domain regulates transcription	  7	1	1	0	7	1258	4696	0
R-HSA-2206281	Mucopolysaccharidoses	  8	0.850065813595789	1	1	7	1257	4696	0.592309220985692
R-HSA-2214320	Anchoring fibril formation	 10	0.906743192466844	1	1	9	1257	4694	0.473847376788553
R-HSA-2219528	PI3K/AKT Signaling in Cancer	 53	0.132345237145438	1	15	38	1243	4665	1.34107748147704
R-HSA-2219530	Constitutive Signaling by Aberrant PI3K in Cancer	 32	0.0574073866945489	1	11	21	1247	4682	1.62885035771065
R-HSA-2243919	Crosslinking of collagen fibrils	 13	0.954269742184979	1	1	12	1257	4691	0.364497982145041
R-HSA-2262749	Cellular response to hypoxia	 58	0.997006933608429	1	5	53	1253	4650	0.408489117921167
R-HSA-2299718	Condensation of Prophase Chromosomes	 15	0.193605883409086	1	5	10	1253	4693	1.57949125596184
R-HSA-2404192	Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	 27	0.0053820855099796	0.423715563331436	12	15	1246	4688	2.10598834128246
R-HSA-2408517	SeMet incorporation into proteins	 10	0.35569981181152	1	3	7	1255	4696	1.42154213036566
R-HSA-2408522	Selenoamino acid metabolism	 37	0.240725052201459	1	10	27	1248	4676	1.28066858591501
R-HSA-2408557	Selenocysteine synthesis	 21	0.272216071960465	1	6	15	1252	4688	1.3538496479673
R-HSA-2424491	DAP12 signaling	 15	0.85715519636857	1	2	13	1256	4690	0.631796502384738
R-HSA-2426168	Activation of gene expression by SREBF (SREBP)	 33	0.139804064713026	1	10	23	1248	4680	1.43590114178349
R-HSA-2428924	IGF1R signaling cascade	 27	0.0053820855099796	0.423715563331436	12	15	1246	4688	2.10598834128246
R-HSA-2428928	IRS-related events triggered by IGF1R	 26	0.00368700854484829	0.423715563331436	12	14	1246	4689	2.18698789287025
R-HSA-2428933	SHC-related events triggered by IGF1R	  9	0.596590649481565	1	2	7	1256	4696	1.05299417064123
R-HSA-2453864	Retinoid cycle disease events	  6	1	1	0	6	1258	4697	0
R-HSA-2453902	The canonical retinoid cycle in rods (twilight vision)	 12	0.942006117300883	1	1	11	1257	4692	0.394872813990461
R-HSA-2454202	Fc epsilon receptor (FCERI) signaling	 96	0.960791178310948	1	14	82	1244	4621	0.691027424483307
R-HSA-2465910	MASTL Facilitates Mitotic Progression	  9	0.596590649481565	1	2	7	1256	4696	1.05299417064123
R-HSA-2468052	Establishment of Sister Chromatid Cohesion	  9	0.596590649481565	1	2	7	1256	4696	1.05299417064123
R-HSA-2470946	Cohesin Loading onto Chromatin	 10	0.140936259771786	1	4	6	1254	4697	1.89538950715421
R-HSA-2474795	Diseases associated with visual transduction	  6	1	1	0	6	1258	4697	0
R-HSA-2500257	Resolution of Sister Chromatid Cohesion	 70	0.945567624651559	1	10	60	1248	4643	0.676924823983648
R-HSA-2514853	Condensation of Prometaphase Chromosomes	  5	0.0666681617559274	1	3	2	1255	4701	2.84308426073132
R-HSA-2514856	The phototransduction cascade	 14	0.154445975766771	1	5	9	1253	4694	1.69231205995912
R-HSA-2514859	Inactivation, recovery and regulation of the phototransduction cascade	 14	0.154445975766771	1	5	9	1253	4694	1.69231205995912
R-HSA-2559580	Oxidative Stress Induced Senescence	 48	0.197071440112928	1	13	35	1245	4668	1.283336645469
R-HSA-2559582	Senescence-Associated Secretory Phenotype (SASP)	 42	0.986310980693508	1	4	38	1254	4665	0.451283215989098
R-HSA-2559583	Cellular Senescence	 94	0.718929106764636	1	18	76	1240	4627	0.907367317254677
R-HSA-2559584	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	 10	0.656813358899076	1	2	8	1256	4695	0.947694753577107
R-HSA-2559585	Oncogene Induced Senescence	 21	0.056719331454607	1	8	13	1250	4690	1.80513286395639
R-HSA-2559586	DNA Damage/Telomere Stress Induced Senescence	 28	0.734415020592046	1	5	23	1253	4680	0.846156029979559
R-HSA-2562578	TRIF-mediated programmed cell death	  5	0.694448590316415	1	1	4	1257	4699	0.947694753577107
R-HSA-2565942	Regulation of PLK1 Activity at G2/M Transition	 63	0.0312219007945247	0.832120089163637	20	43	1238	4660	1.50427738663033
R-HSA-2586552	Signaling by Leptin	  9	0.100768114047514	1	4	5	1254	4698	2.10598834128246
R-HSA-2644602	Signaling by NOTCH1 PEST Domain Mutants in Cancer	 49	0.464369077446242	1	11	38	1247	4665	1.06373900911716
R-HSA-2644603	Signaling by NOTCH1 in Cancer	 49	0.464369077446242	1	11	38	1247	4665	1.06373900911716
R-HSA-2644605	FBXW7 Mutants and NOTCH1 in Cancer	  5	1	1	0	5	1258	4698	0
R-HSA-2644606	Constitutive Signaling by NOTCH1 PEST Domain Mutants	 49	0.464369077446242	1	11	38	1247	4665	1.06373900911716
R-HSA-2644607	Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling	  5	1	1	0	5	1258	4698	0
R-HSA-264642	Acetylcholine Neurotransmitter Release Cycle	 13	0.794842618691727	1	2	11	1256	4692	0.728995964290082
R-HSA-264870	Caspase-mediated cleavage of cytoskeletal proteins	 10	0.140936259771786	1	4	6	1254	4697	1.89538950715421
R-HSA-264876	Insulin processing	 25	0.264121413735838	1	7	18	1251	4685	1.32677265500795
R-HSA-2660825	Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	  7	0.167421732949172	1	3	4	1255	4699	2.03077447195094
R-HSA-2660826	Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	  7	0.167421732949172	1	3	4	1255	4699	2.03077447195094
R-HSA-2672351	Stimuli-sensing channels	 60	0.0184123408648912	0.646792486792331	20	40	1238	4663	1.57949125596184
R-HSA-2682334	EPH-Ephrin signaling	 66	0.915030279093002	1	10	56	1248	4647	0.717950570891747
R-HSA-2691230	Signaling by NOTCH1 HD Domain Mutants in Cancer	 12	0.480543217269381	1	3	9	1255	4694	1.18461844197138
R-HSA-2691232	Constitutive Signaling by NOTCH1 HD Domain Mutants	 12	0.480543217269381	1	3	9	1255	4694	1.18461844197138
R-HSA-2730905	Role of LAT2/NTAL/LAB on calcium mobilization	 14	0.82853459821947	1	2	12	1256	4691	0.676924823983648
R-HSA-2871796	FCERI mediated MAPK activation	 22	0.994620836104421	1	1	21	1257	4682	0.215385171267524
R-HSA-2871809	FCERI mediated Ca+2 mobilization	 20	0.635673802887573	1	4	16	1254	4687	0.947694753577107
R-HSA-2871837	FCERI mediated NF-kB activation	 63	0.883525918637126	1	10	53	1248	4650	0.752138693315164
R-HSA-2892247	POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation	  5	0.694448590316415	1	1	4	1257	4699	0.947694753577107
R-HSA-2894858	Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	 49	0.464369077446242	1	11	38	1247	4665	1.06373900911716
R-HSA-2894862	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	 49	0.464369077446242	1	11	38	1247	4665	1.06373900911716
R-HSA-2979096	NOTCH2 Activation and Transmission of Signal to the Nucleus	 16	0.235752807215477	1	5	11	1253	4692	1.48077305246423
R-HSA-2980736	Peptide hormone metabolism	 50	0.63165119811778	1	10	40	1248	4663	0.947694753577107
R-HSA-2980766	Nuclear Envelope Breakdown	 39	0.44300159299677	1	9	30	1249	4673	1.09349394643512
R-HSA-2990846	SUMOylation	 74	0.133796816920034	1	20	54	1238	4649	1.28066858591501
R-HSA-2993913	Clearance of Nuclear Envelope Membranes from Chromatin	  8	0.850065813595789	1	1	7	1257	4696	0.592309220985692
R-HSA-2995383	Initiation of Nuclear Envelope Reformation	 12	0.755417103399376	1	2	10	1256	4693	0.789745627980922
R-HSA-2995410	Nuclear Envelope Reassembly	 12	0.755417103399376	1	2	10	1256	4693	0.789745627980922
R-HSA-3000157	Laminin interactions	 23	0.552202797361461	1	5	18	1253	4685	1.03010299301859
R-HSA-3000170	Syndecan interactions	 20	0.109003485304835	1	7	13	1251	4690	1.65846581875994
R-HSA-3000171	Non-integrin membrane-ECM interactions	 45	0.630752339350129	1	9	36	1249	4667	0.947694753577106
R-HSA-3000178	ECM proteoglycans	 47	0.80501876596026	1	8	39	1250	4664	0.806548726448601
R-HSA-3000480	Scavenging by Class A Receptors	 13	0.954269742184979	1	1	12	1257	4691	0.364497982145041
R-HSA-3108214	SUMOylation of DNA damage response and repair proteins	 51	0.171553382339251	1	14	37	1244	4666	1.30075750490975
R-HSA-3108232	SUMO E3 ligases SUMOylate target proteins	 71	0.0959677360580422	1	20	51	1238	4652	1.33478134306635
R-HSA-3134963	DEx/H-box helicases activate type I IFN and inflammatory cytokines production 	 11	0.709604789044377	1	2	9	1256	4694	0.861540685070097
R-HSA-3134973	LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production	  5	0.285442766330515	1	2	3	1256	4700	1.89538950715421
R-HSA-3134975	Regulation of innate immune responses to cytosolic DNA	  8	0.528741782085573	1	2	6	1256	4697	1.18461844197138
R-HSA-3214815	HDACs deacetylate histones	 31	0.994108420717148	1	2	29	1256	4674	0.305707985024873
R-HSA-3214841	PKMTs methylate histone lysines	 31	0.190589305250759	1	9	22	1249	4681	1.37568593261193
R-HSA-3214842	HDMs demethylate histones	 21	0.67594281950565	1	4	17	1254	4686	0.902566431978197
R-HSA-3214847	HATs acetylate histones	 68	0.589848149509018	1	14	54	1244	4649	0.975568128682316
R-HSA-3214858	RMTs methylate histone arginines	 28	0.223970936590072	1	8	20	1250	4683	1.3538496479673
R-HSA-3215018	Processing and activation of SUMO	  6	1	1	0	6	1258	4697	0
R-HSA-3229121	Glycogen storage diseases	  8	0.850065813595789	1	1	7	1257	4696	0.592309220985692
R-HSA-3232118	SUMOylation of transcription factors	 10	0.656813358899076	1	2	8	1256	4695	0.947694753577107
R-HSA-3238698	WNT ligand biogenesis and trafficking	 10	0.656813358899076	1	2	8	1256	4695	0.947694753577107
R-HSA-3270619	IRF3-mediated induction of type I IFN	  9	0.881750209110067	1	1	8	1257	4695	0.526497085320615
R-HSA-3295583	TRP channels	 11	0.186227514654976	1	4	7	1254	4696	1.72308137014019
R-HSA-3296469	Defects in cobalamin (B12) metabolism	 10	0.140936259771786	1	4	6	1254	4697	1.89538950715421
R-HSA-3296482	Defects in vitamin and cofactor metabolism	 14	0.0552197419581444	1	6	8	1252	4695	2.03077447195094
R-HSA-3299685	Detoxification of Reactive Oxygen Species	 23	0.746858372799286	1	4	19	1254	4684	0.824082394414875
R-HSA-3301854	Nuclear Pore Complex (NPC) Disassembly	 26	0.478712348801691	1	6	20	1252	4683	1.09349394643512
R-HSA-3304349	Loss of Function of SMAD2/3 in Cancer	  6	0.371762497819815	1	2	4	1256	4699	1.57949125596184
R-HSA-3304351	Signaling by TGF-beta Receptor Complex in Cancer	  7	0.453498803768073	1	2	5	1256	4698	1.3538496479673
R-HSA-3304356	SMAD2/3 Phosphorylation Motif Mutants in Cancer	  5	0.694448590316415	1	1	4	1257	4699	0.947694753577107
R-HSA-3315487	SMAD2/3 MH2 Domain Mutants in Cancer	  6	0.371762497819815	1	2	4	1256	4699	1.57949125596184
R-HSA-3322077	Glycogen synthesis	 10	0.656813358899076	1	2	8	1256	4695	0.947694753577107
R-HSA-3371378	Regulation by c-FLIP	  7	0.809900309657012	1	1	6	1257	4697	0.676924823983648
R-HSA-3371453	Regulation of HSF1-mediated heat shock response	 63	0.937490500058624	1	9	54	1249	4649	0.676924823983648
R-HSA-3371497	HSP90 chaperone cycle for steroid hormone receptors (SHR)	 41	0.999300778266394	1	2	39	1256	4664	0.231145061848075
R-HSA-3371511	HSF1 activation	 23	0.969553696859762	1	2	21	1256	4682	0.412041197207438
R-HSA-3371556	Cellular response to heat stress	 79	0.878859359699905	1	13	66	1245	4637	0.779748847879898
R-HSA-3371568	Attenuation phase	 20	0.991342246690517	1	1	19	1257	4684	0.236923688394277
R-HSA-3371571	HSF1-dependent transactivation	 28	0.98900310510335	1	2	26	1256	4677	0.338462411991824
R-HSA-349425	Autodegradation of the E3 ubiquitin ligase COP1	 39	0.97719114961278	1	4	35	1254	4668	0.485997309526721
R-HSA-350054	Notch-HLH transcription pathway	 10	0.656813358899076	1	2	8	1256	4695	0.947694753577107
R-HSA-350562	Regulation of ornithine decarboxylase (ODC)	 41	0.995844305701153	1	3	38	1255	4665	0.346717592772112
R-HSA-351202	Metabolism of polyamines	 63	0.99971565575568	1	4	59	1254	4644	0.300855477326066
R-HSA-351906	Apoptotic cleavage of cell adhesion  proteins	  7	1	1	0	7	1258	4696	0
R-HSA-352230	Amino acid transport across the plasma membrane	 21	0.67594281950565	1	4	17	1254	4686	0.902566431978197
R-HSA-354192	Integrin alphaIIb beta3 signaling	 16	0.687843131132348	1	3	13	1255	4690	0.888463831478537
R-HSA-354194	GRB2:SOS provides linkage to MAPK signaling for Integrins 	  8	0.528741782085573	1	2	6	1256	4697	1.18461844197138
R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	 28	0.95377919798048	1	3	25	1255	4678	0.507693617987736
R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	 14	0.82853459821947	1	2	12	1256	4691	0.676924823983648
R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	 15	0.85715519636857	1	2	13	1256	4690	0.631796502384738
R-HSA-3595172	Defective CHST3 causes SEDCJD	  7	0.809900309657012	1	1	6	1257	4697	0.676924823983648
R-HSA-3595174	Defective CHST14 causes EDS, musculocontractural type	  8	0.850065813595789	1	1	7	1257	4696	0.592309220985692
R-HSA-3595177	Defective CHSY1 causes TPBS	  8	0.850065813595789	1	1	7	1257	4696	0.592309220985692
R-HSA-3656225	Defective CHST6 causes MCDC1	  5	0.694448590316415	1	1	4	1257	4699	0.947694753577107
R-HSA-3656237	Defective EXT2 causes exostoses 2	  8	0.850065813595789	1	1	7	1257	4696	0.592309220985692
R-HSA-3656244	Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)	  5	0.694448590316415	1	1	4	1257	4699	0.947694753577107
R-HSA-3656253	Defective EXT1 causes exostoses 1, TRPS2 and CHDS	  8	0.850065813595789	1	1	7	1257	4696	0.592309220985692
R-HSA-3656532	TGFBR1 KD Mutants in Cancer	  6	0.758985808815735	1	1	5	1257	4698	0.789745627980922
R-HSA-3656534	Loss of Function of TGFBR1 in Cancer	  6	0.758985808815735	1	1	5	1257	4698	0.789745627980922
R-HSA-372708	p130Cas linkage to MAPK signaling for integrins	  7	0.809900309657012	1	1	6	1257	4697	0.676924823983648
R-HSA-373080	Class B/2 (Secretin family receptors)	 47	0.951094488620118	1	6	41	1252	4662	0.604911544836451
R-HSA-373752	Netrin-1 signaling	 38	0.56726627761331	1	8	30	1250	4673	0.997573424818007
R-HSA-373753	Nephrin family interactions	 17	0.728723766275771	1	3	14	1255	4689	0.83620125315627
R-HSA-373755	Semaphorin interactions	 51	0.997249955356416	1	4	47	1254	4656	0.371645001402787
R-HSA-373760	L1CAM interactions	 84	0.720043184668848	1	16	68	1242	4635	0.902566431978197
R-HSA-375165	NCAM signaling for neurite out-growth	 42	0.391559353454795	1	10	32	1248	4671	1.12820803997275
R-HSA-375170	CDO in myogenesis	 19	0.372319270008444	1	5	14	1253	4689	1.24696678102251
R-HSA-375276	Peptide ligand-binding receptors	 74	0.999967649409387	1	4	70	1254	4633	0.256133717183002
R-HSA-375280	Amine ligand-binding receptors	 18	0.98606788331447	1	1	17	1257	4686	0.263248542660307
R-HSA-376172	DSCAM interactions	  8	1	1	0	8	1258	4695	0
R-HSA-3769402	Deactivation of the beta-catenin transactivating complex	 29	0.998984502291	1	1	28	1257	4675	0.163395647168467
R-HSA-3772470	Negative regulation of TCF-dependent signaling by WNT ligand antagonists	  6	0.758985808815735	1	1	5	1257	4698	0.789745627980922
R-HSA-3781860	Diseases associated with N-glycosylation of proteins	 10	0.35569981181152	1	3	7	1255	4696	1.42154213036566
R-HSA-3781865	Diseases of glycosylation	 80	0.966371433267231	1	11	69	1247	4634	0.651540143084261
R-HSA-3785653	Myoclonic epilepsy of Lafora	  5	0.694448590316415	1	1	4	1257	4699	0.947694753577107
R-HSA-379716	Cytosolic tRNA aminoacylation	 21	0.851361715004481	1	3	18	1255	4685	0.676924823983648
R-HSA-379724	tRNA Aminoacylation	 32	0.526996626558664	1	7	25	1251	4678	1.03654113672496
R-HSA-379726	Mitochondrial tRNA aminoacylation	 13	0.287098043862492	1	4	9	1254	4694	1.45799192858016
R-HSA-380108	Chemokine receptors bind chemokines	 18	0.98606788331447	1	1	17	1257	4686	0.263248542660307
R-HSA-380259	Loss of Nlp from mitotic centrosomes	 52	0.00743167896997425	0.423715563331436	19	33	1239	4670	1.73136541518894
R-HSA-380270	Recruitment of mitotic centrosome proteins and complexes	 59	0.0152062974350806	0.578684096835011	20	39	1238	4664	1.60626229419849
R-HSA-380284	Loss of proteins required for interphase microtubule organization from the centrosome	 52	0.00743167896997425	0.423715563331436	19	33	1239	4670	1.73136541518894
R-HSA-380287	Centrosome maturation	 59	0.0152062974350806	0.578684096835011	20	39	1238	4664	1.60626229419849
R-HSA-380320	Recruitment of NuMA to mitotic centrosomes	 65	0.0428672425052738	0.932192416384526	20	45	1238	4658	1.45799192858016
R-HSA-380972	Energy dependent regulation of mTOR by LKB1-AMPK	 22	0.164036518152948	1	7	15	1251	4688	1.50769619887267
R-HSA-380994	ATF4 activates genes	 18	0.545978248712532	1	4	14	1254	4689	1.05299417064123
R-HSA-381033	ATF6 (ATF6-alpha) activates chaperones	  9	0.0244332470772493	0.743856633240702	5	4	1253	4699	2.63248542660307
R-HSA-381038	XBP1(S) activates chaperone genes	 40	0.769716264642714	1	7	33	1251	4670	0.829232909379968
R-HSA-381042	PERK regulates gene expression	 21	0.67594281950565	1	4	17	1254	4686	0.902566431978197
R-HSA-381070	IRE1alpha activates chaperones	 41	0.792376510959752	1	7	34	1251	4669	0.809007716468262
R-HSA-381119	Unfolded Protein Response (UPR)	 69	0.613727168756926	1	14	55	1244	4648	0.961429460150688
R-HSA-381183	ATF6 (ATF6-alpha) activates chaperone genes	  7	0.0399787305555638	0.895270593253458	4	3	1254	4700	2.70769929593459
R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	 64	0.821815251316774	1	11	53	1247	4650	0.814425178855326
R-HSA-381426	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	 77	0.913218328116013	1	12	65	1246	4638	0.738463444345797
R-HSA-381676	Glucagon-like Peptide-1 (GLP1) regulates insulin secretion	 33	0.85584688348084	1	5	28	1253	4675	0.717950570891747
R-HSA-381753	Olfactory Signaling Pathway	 12	0.755417103399376	1	2	10	1256	4693	0.789745627980922
R-HSA-381771	Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)	 11	0.709604789044377	1	2	9	1256	4694	0.861540685070097
R-HSA-382556	ABC-family proteins mediated transport	 71	0.320821637047585	1	17	54	1241	4649	1.1345641416064
R-HSA-383280	Nuclear Receptor transcription pathway	 27	0.518839649379423	1	6	21	1252	4682	1.05299417064123
R-HSA-388841	Costimulation by the CD28 family	 43	0.714247860775783	1	8	35	1250	4668	0.881576514955448
R-HSA-388844	Receptor-type tyrosine-protein phosphatases	 17	0.728723766275771	1	3	14	1255	4689	0.83620125315627
R-HSA-389356	CD28 co-stimulation	 22	0.713005229244882	1	4	18	1254	4685	0.861540685070097
R-HSA-389357	CD28 dependent PI3K/Akt signaling	 14	0.592690741525265	1	3	11	1255	4692	1.01538723597547
R-HSA-389359	CD28 dependent Vav1 pathway	  8	1	1	0	8	1258	4695	0
R-HSA-389513	CTLA4 inhibitory signaling	 18	0.161096514800637	1	6	12	1252	4691	1.57949125596184
R-HSA-389661	Glyoxylate metabolism and glycine degradation	 17	0.901691816657284	1	2	15	1256	4688	0.55746750210418
R-HSA-389887	Beta-oxidation of pristanoyl-CoA	  5	0.285442766330515	1	2	3	1256	4700	1.89538950715421
R-HSA-389948	PD-1 signaling	 10	0.906743192466844	1	1	9	1257	4694	0.473847376788553
R-HSA-389957	Prefoldin mediated transfer of substrate  to CCT/TriC	 18	0.98606788331447	1	1	17	1257	4686	0.263248542660307
R-HSA-389958	Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding	 19	0.989017000391771	1	1	18	1257	4685	0.249393356204502
R-HSA-389960	Formation of tubulin folding intermediates by CCT/TriC	 17	1	1	0	17	1258	4686	0
R-HSA-389977	Post-chaperonin tubulin folding pathway	 14	1	1	0	14	1258	4689	0
R-HSA-390247	Beta-oxidation of very long chain fatty acids	  6	0.758985808815735	1	1	5	1257	4698	0.789745627980922
R-HSA-390450	Folding of actin by CCT/TriC	  9	1	1	0	9	1258	4694	0
R-HSA-390466	Chaperonin-mediated protein folding	 57	0.936307124511881	1	8	49	1250	4654	0.665048949878671
R-HSA-390471	Association of TriC/CCT with target proteins during biosynthesis	 26	0.830064425387061	1	4	22	1254	4681	0.728995964290082
R-HSA-390522	Striated Muscle Contraction	 13	0.794842618691727	1	2	11	1256	4692	0.728995964290082
R-HSA-390666	Serotonin receptors	  6	1	1	0	6	1258	4697	0
R-HSA-3906995	Diseases associated with O-glycosylation of proteins	 32	0.977380083756183	1	3	29	1255	4674	0.444231915739269
R-HSA-390918	Peroxisomal lipid metabolism	 15	0.642500710250324	1	3	12	1255	4691	0.947694753577107
R-HSA-391160	Signal regulatory protein family interactions	 10	0.656813358899076	1	2	8	1256	4695	0.947694753577107
R-HSA-391251	Protein folding	 62	0.966162653090458	1	8	54	1250	4649	0.611415970049746
R-HSA-391903	Eicosanoid ligand-binding receptors	  5	1	1	0	5	1258	4698	0
R-HSA-392154	Nitric oxide stimulates guanylate cyclase	 16	0.100882651035028	1	6	10	1252	4693	1.77692766295707
R-HSA-392170	ADP signalling through P2Y purinoceptor 12	 16	0.977584391900723	1	1	15	1257	4688	0.296154610492846
R-HSA-392451	G beta:gamma signalling through PI3Kgamma	 28	0.98900310510335	1	2	26	1256	4677	0.338462411991824
R-HSA-392517	Rap1 signalling	 12	0.755417103399376	1	2	10	1256	4693	0.789745627980922
R-HSA-392518	Signal amplification	 23	0.746858372799286	1	4	19	1254	4684	0.824082394414875
R-HSA-392851	Prostacyclin signalling through prostacyclin receptor	 13	0.954269742184979	1	1	12	1257	4691	0.364497982145041
R-HSA-3928662	EPHB-mediated forward signaling	 33	0.939580268209148	1	4	29	1254	4674	0.574360456713398
R-HSA-3928663	EPHA-mediated growth cone collapse	 18	0.765272869788419	1	3	15	1255	4688	0.789745627980922
R-HSA-3928664	Ephrin signaling	 13	0.954269742184979	1	1	12	1257	4691	0.364497982145041
R-HSA-3928665	EPH-ephrin mediated repulsion of cells	 35	0.778575665182788	1	6	29	1252	4674	0.812309788780377
R-HSA-397795	G-protein beta:gamma signalling	 30	0.992739157142693	1	2	28	1256	4675	0.315898251192369
R-HSA-399719	Trafficking of AMPA receptors	 27	0.852187264802933	1	4	23	1254	4680	0.70199611376082
R-HSA-399721	Glutamate binding, activation of AMPA receptors and synaptic plasticity	 27	0.852187264802933	1	4	23	1254	4680	0.70199611376082
R-HSA-399954	Sema3A PAK dependent Axon repulsion	 13	1	1	0	13	1258	4690	0
R-HSA-399955	SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion	 11	0.926457032809091	1	1	10	1257	4693	0.430770342535048
R-HSA-399956	CRMPs in Sema3A signaling	 13	1	1	0	13	1258	4690	0
R-HSA-399997	Acetylcholine regulates insulin secretion	  7	0.453498803768073	1	2	5	1256	4698	1.3538496479673
R-HSA-400042	Adrenaline,noradrenaline inhibits insulin secretion	 22	0.994620836104421	1	1	21	1257	4682	0.215385171267524
R-HSA-400206	Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	 85	0.330510875894312	1	20	65	1238	4638	1.11493500420836
R-HSA-400253	Circadian Clock	 55	0.632772721530589	1	11	44	1247	4659	0.947694753577107
R-HSA-400451	Free fatty acids regulate insulin secretion	  5	0.285442766330515	1	2	3	1256	4700	1.89538950715421
R-HSA-400508	Incretin synthesis, secretion, and inactivation	 11	0.709604789044377	1	2	9	1256	4694	0.861540685070097
R-HSA-400511	Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)	  7	0.453498803768073	1	2	5	1256	4698	1.3538496479673
R-HSA-400685	Sema4D in semaphorin signaling	 19	0.932983775923062	1	2	17	1256	4686	0.498786712409003
R-HSA-4085001	Sialic acid metabolism	 24	0.97510129524537	1	2	22	1256	4681	0.394872813990461
R-HSA-4086398	Ca2+ pathway	 47	0.404770187216433	1	11	36	1247	4667	1.10900449886683
R-HSA-4086400	PCP/CE pathway	 67	0.997786194460697	1	6	61	1252	4642	0.42434093443751
R-HSA-416476	G alpha (q) signalling events	 87	0.997538798936378	1	9	78	1249	4625	0.4901869415054
R-HSA-416482	G alpha (12/13) signalling events	 53	0.897793713763431	1	8	45	1250	4658	0.71524132345442
R-HSA-416550	Sema4D mediated inhibition of cell attachment and migration	  7	0.809900309657012	1	1	6	1257	4697	0.676924823983648
R-HSA-416572	Sema4D induced cell migration and growth-cone collapse	 16	0.881342634259459	1	2	14	1256	4689	0.592309220985692
R-HSA-416700	Other semaphorin interactions	 13	0.794842618691727	1	2	11	1256	4692	0.728995964290082
R-HSA-416993	Trafficking of GluR2-containing AMPA receptors	 14	0.82853459821947	1	2	12	1256	4691	0.676924823983648
R-HSA-417957	P2Y receptors	  6	0.758985808815735	1	1	5	1257	4698	0.789745627980922
R-HSA-418038	Nucleotide-like (purinergic) receptors	  9	0.881750209110067	1	1	8	1257	4695	0.526497085320615
R-HSA-418217	G beta:gamma signalling through PLC beta	 14	1	1	0	14	1258	4689	0
R-HSA-418346	Platelet homeostasis	 61	0.296465500170867	1	15	46	1243	4657	1.16519846751284
R-HSA-418359	Reduction of cytosolic Ca++ levels	 10	0.656813358899076	1	2	8	1256	4695	0.947694753577107
R-HSA-418360	Platelet calcium homeostasis	 18	0.325876881589819	1	5	13	1253	4690	1.31624271330154
R-HSA-418457	cGMP effects	 12	0.0879264616194264	1	5	7	1253	4696	1.97436406995231
R-HSA-418555	G alpha (s) signalling events	 74	0.72208549487843	1	14	60	1244	4643	0.896468010140506
R-HSA-418592	ADP signalling through P2Y purinoceptor 1	 18	0.918744185015892	1	2	16	1256	4687	0.526497085320615
R-HSA-418597	G alpha (z) signalling events	 38	0.92704060053972	1	5	33	1253	4670	0.623483390511254
R-HSA-418885	DCC mediated attractive signaling	 11	0.419251923245224	1	3	8	1255	4695	1.29231102760515
R-HSA-418886	Netrin mediated repulsion signals	  9	0.596590649481565	1	2	7	1256	4696	1.05299417064123
R-HSA-418889	Ligand-independent caspase activation via DCC	  8	1	1	0	8	1258	4695	0
R-HSA-418890	Role of second messengers in netrin-1 signaling	  5	0.694448590316415	1	1	4	1257	4699	0.947694753577107
R-HSA-418990	Adherens junctions interactions	 23	0.995760251524633	1	1	22	1257	4681	0.206020598603719
R-HSA-419037	NCAM1 interactions	 25	0.264121413735838	1	7	18	1251	4685	1.32677265500795
R-HSA-419408	Lysosphingolipid and LPA receptors	 10	0.906743192466844	1	1	9	1257	4694	0.473847376788553
R-HSA-419812	Calcitonin-like ligand receptors	  6	0.758985808815735	1	1	5	1257	4698	0.789745627980922
R-HSA-420029	Tight junction interactions	 10	1	1	0	10	1258	4693	0
R-HSA-420092	Glucagon-type ligand receptors	 19	0.989017000391771	1	1	18	1257	4685	0.249393356204502
R-HSA-420499	Class C/3 (Metabotropic glutamate/pheromone receptors)	  9	0.596590649481565	1	2	7	1256	4696	1.05299417064123
R-HSA-420597	Nectin/Necl  trans heterodimerization	  6	1	1	0	6	1258	4697	0
R-HSA-421270	Cell-cell junction organization	 34	0.99686840405138	1	2	32	1256	4671	0.27873375105209
R-HSA-421837	Clathrin derived vesicle budding	 52	0.0655765238993941	1	16	36	1242	4667	1.45799192858016
R-HSA-422085	Synthesis, secretion, and deacylation of Ghrelin	 10	0.35569981181152	1	3	7	1255	4696	1.42154213036566
R-HSA-422356	Regulation of insulin secretion	 63	0.883525918637126	1	10	53	1248	4650	0.752138693315164
R-HSA-425366	Transport of bile salts and organic acids, metal ions and amine compounds	 55	0.849706470466562	1	9	46	1249	4657	0.775386616563087
R-HSA-425381	Bicarbonate transporters	  5	0.285442766330515	1	2	3	1256	4700	1.89538950715421
R-HSA-425393	Transport of inorganic cations/anions and amino acids/oligopeptides	 63	0.805252904474666	1	11	52	1247	4651	0.82735256264668
R-HSA-425397	Transport of vitamins, nucleosides, and related molecules	 23	0.746858372799286	1	4	19	1254	4684	0.824082394414875
R-HSA-425410	Metal ion SLC transporters	 19	0.592287309700289	1	4	15	1254	4688	0.997573424818007
R-HSA-425561	Sodium/Calcium exchangers	  8	0.528741782085573	1	2	6	1256	4697	1.18461844197138
R-HSA-426486	Small interfering RNA (siRNA) biogenesis	  8	0.227769868815571	1	3	5	1255	4698	1.77692766295707
R-HSA-426496	Post-transcriptional silencing by small RNAs	  7	0.00594873736322812	0.423715563331436	5	2	1253	4701	3.38462411991824
R-HSA-427359	SIRT1 negatively regulates rRNA expression	 13	0.794842618691727	1	2	11	1256	4692	0.728995964290082
R-HSA-427389	ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression	 23	0.892159841381082	1	3	20	1255	4683	0.618061795811156
R-HSA-427413	NoRC negatively regulates rRNA expression	 42	0.158079276240341	1	12	30	1246	4673	1.3538496479673
R-HSA-428157	Sphingolipid metabolism	 59	0.608936083957923	1	12	47	1246	4656	0.963757376519091
R-HSA-428540	Activation of RAC1	 10	0.140936259771786	1	4	6	1254	4697	1.89538950715421
R-HSA-428542	Regulation of commissural axon pathfinding by SLIT and ROBO	  9	0.881750209110067	1	1	8	1257	4695	0.526497085320615
R-HSA-428543	Inactivation of CDC42 and RAC1	  6	0.112803303351911	1	3	3	1255	4700	2.36923688394277
R-HSA-428643	Organic anion transporters	  6	1	1	0	6	1258	4697	0
R-HSA-428890	Role of ABL in ROBO-SLIT signaling	  6	0.758985808815735	1	1	5	1257	4698	0.789745627980922
R-HSA-428930	Thromboxane signalling through TP receptor	 16	0.687843131132348	1	3	13	1255	4690	0.888463831478537
R-HSA-429914	Deadenylation-dependent mRNA decay	 40	0.329340604309458	1	10	30	1248	4673	1.18461844197138
R-HSA-429947	Deadenylation of mRNA	 16	0.100882651035028	1	6	10	1252	4693	1.77692766295707
R-HSA-429958	mRNA decay by 3' to 5' exoribonuclease	 14	0.963941676336172	1	1	13	1257	4690	0.338462411991824
R-HSA-430039	mRNA decay by 5' to 3' exoribonuclease	 10	0.35569981181152	1	3	7	1255	4696	1.42154213036566
R-HSA-430116	GP1b-IX-V activation signalling	  7	0.809900309657012	1	1	6	1257	4697	0.676924823983648
R-HSA-432040	Vasopressin regulates renal water homeostasis via Aquaporins	 32	0.836109088834723	1	5	27	1253	4676	0.740386526232115
R-HSA-432142	Platelet sensitization by LDL	 15	0.393450866625033	1	4	11	1254	4692	1.26359300476948
R-HSA-432720	Lysosome Vesicle Biogenesis	 22	0.713005229244882	1	4	18	1254	4685	0.861540685070097
R-HSA-432722	Golgi Associated Vesicle Biogenesis	 42	0.0443991862337683	0.950420080316602	14	28	1244	4675	1.57949125596184
R-HSA-434316	Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion	  5	0.285442766330515	1	2	3	1256	4700	1.89538950715421
R-HSA-435354	Zinc transporters	 14	0.34015887110078	1	4	10	1254	4693	1.3538496479673
R-HSA-435368	Zinc efflux and compartmentalization by the SLC30 family	  6	0.371762497819815	1	2	4	1256	4699	1.57949125596184
R-HSA-437239	Recycling pathway of L1	 34	0.873559714865674	1	5	29	1253	4674	0.696834377630225
R-HSA-438064	Post NMDA receptor activation events	 30	0.790028024585653	1	5	25	1253	4678	0.789745627980922
R-HSA-438066	Unblocking of NMDA receptor, glutamate binding and activation	 15	0.85715519636857	1	2	13	1256	4690	0.631796502384738
R-HSA-4411364	Binding of TCF/LEF:CTNNB1 to target gene promoters	  7	1	1	0	7	1258	4696	0
R-HSA-4419969	Depolymerisation of the Nuclear Lamina	 11	0.709604789044377	1	2	9	1256	4694	0.861540685070097
R-HSA-4420097	VEGFA-VEGFR2 Pathway	 74	0.933924639529616	1	11	63	1247	4640	0.704367722253255
R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	 15	0.85715519636857	1	2	13	1256	4690	0.631796502384738
R-HSA-442380	Zinc influx into cells by the SLC39 gene family	  8	0.528741782085573	1	2	6	1256	4697	1.18461844197138
R-HSA-442660	Na+/Cl- dependent neurotransmitter transporters	 10	0.656813358899076	1	2	8	1256	4695	0.947694753577107
R-HSA-442720	CREB phosphorylation through the activation of Adenylate Cyclase	  5	1	1	0	5	1258	4698	0
R-HSA-442729	CREB phosphorylation through the activation of CaMKII	 13	0.794842618691727	1	2	11	1256	4692	0.728995964290082
R-HSA-442742	CREB phosphorylation through the activation of Ras	 25	0.632229019791489	1	5	20	1253	4683	0.947694753577107
R-HSA-442755	Activation of NMDA receptor and postsynaptic events	 34	0.7531124614488	1	6	28	1252	4675	0.83620125315627
R-HSA-442982	Ras activation uopn Ca2+ infux through NMDA receptor	 15	0.85715519636857	1	2	13	1256	4690	0.631796502384738
R-HSA-444257	RSK activation	  6	0.371762497819815	1	2	4	1256	4699	1.57949125596184
R-HSA-445095	Interaction between L1 and Ankyrins	 24	0.97510129524537	1	2	22	1256	4681	0.394872813990461
R-HSA-445144	Signal transduction by L1	 13	0.287098043862492	1	4	9	1254	4694	1.45799192858016
R-HSA-445355	Smooth Muscle Contraction	 29	0.961236003533543	1	3	26	1255	4677	0.4901869415054
R-HSA-445717	Aquaporin-mediated transport	 34	0.873559714865674	1	5	29	1253	4674	0.696834377630225
R-HSA-445989	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	 21	0.464530482260742	1	5	16	1253	4687	1.12820803997275
R-HSA-446107	Type I hemidesmosome assembly	  5	0.285442766330515	1	2	3	1256	4700	1.89538950715421
R-HSA-446193	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	 54	0.908920873272381	1	8	46	1250	4657	0.70199611376082
R-HSA-446210	Synthesis of UDP-N-acetyl-glucosamine	  7	0.809900309657012	1	1	6	1257	4697	0.676924823983648
R-HSA-446219	Synthesis of substrates in N-glycan biosythesis	 45	0.97434482309854	1	5	40	1253	4663	0.526497085320615
R-HSA-446353	Cell-extracellular matrix interactions	 14	0.592690741525265	1	3	11	1255	4692	1.01538723597547
R-HSA-446388	Regulation of cytoskeletal remodeling and cell spreading by IPP complex components	  6	0.371762497819815	1	2	4	1256	4699	1.57949125596184
R-HSA-446652	Interleukin-1 family signaling	 80	0.983976911564255	1	10	70	1248	4633	0.592309220985692
R-HSA-446728	Cell junction organization	 51	0.93561401187848	1	7	44	1251	4659	0.650378752454877
R-HSA-447038	NrCAM interactions	  6	0.758985808815735	1	1	5	1257	4698	0.789745627980922
R-HSA-447041	CHL1 interactions	  6	0.758985808815735	1	1	5	1257	4698	0.789745627980922
R-HSA-447043	Neurofascin interactions	  6	0.112803303351911	1	3	3	1255	4700	2.36923688394277
R-HSA-447115	Interleukin-12 family signaling	 38	0.409761521143426	1	9	29	1249	4674	1.12227010292026
R-HSA-448424	Interleukin-17 signaling	 54	0.833812546586967	1	9	45	1249	4658	0.789745627980922
R-HSA-449836	Other interleukin signaling	 16	0.881342634259459	1	2	14	1256	4689	0.592309220985692
R-HSA-450282	MAPK targets/ Nuclear events mediated by MAP kinases	 28	0.734415020592046	1	5	23	1253	4680	0.846156029979559
R-HSA-450294	MAP kinase activation in TLR cascade	 48	0.710575161431839	1	9	39	1249	4664	0.888463831478537
R-HSA-450302	activated TAK1 mediates p38 MAPK activation	 11	0.709604789044377	1	2	9	1256	4694	0.861540685070097
R-HSA-450321	JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	 12	0.755417103399376	1	2	10	1256	4693	0.789745627980922
R-HSA-450341	Activation of the AP-1 family of transcription factors	  8	1	1	0	8	1258	4695	0
R-HSA-450385	Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA	 16	0.687843131132348	1	3	13	1255	4690	0.888463831478537
R-HSA-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA	 41	0.983746281254152	1	4	37	1254	4666	0.462290123696149
R-HSA-450513	Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA	 16	0.687843131132348	1	3	13	1255	4690	0.888463831478537
R-HSA-450520	HuR (ELAVL1) binds and stabilizes mRNA	  5	0.694448590316415	1	1	4	1257	4699	0.947694753577107
R-HSA-450531	Regulation of mRNA stability by proteins that bind AU-rich elements	 67	0.98273768289274	1	8	59	1250	4644	0.565787912583347
R-HSA-450604	KSRP (KHSRP) binds and destabilizes mRNA	 14	0.963941676336172	1	1	13	1257	4690	0.338462411991824
R-HSA-451306	Ionotropic activity of kainate receptors	  7	0.809900309657012	1	1	6	1257	4697	0.676924823983648
R-HSA-451308	Activation of Ca-permeable Kainate Receptor	  7	0.809900309657012	1	1	6	1257	4697	0.676924823983648
R-HSA-451326	Activation of kainate receptors upon glutamate binding	 21	0.9931755161171	1	1	20	1257	4683	0.225641607994549
R-HSA-451927	Interleukin-2 family signaling	 19	0.797707662304944	1	3	16	1255	4687	0.748180068613505
R-HSA-452723	Transcriptional regulation of pluripotent stem cells	 22	0.312783404638284	1	6	16	1252	4687	1.29231102760515
R-HSA-453276	Regulation of mitotic cell cycle	 56	0.995775150373934	1	5	51	1253	4652	0.42307801498978
R-HSA-453279	Mitotic G1-G1/S phases	100	0.994045854171613	1	12	88	1246	4615	0.568616852146264
R-HSA-4551638	SUMOylation of chromatin organization proteins	 39	0.102221078686239	1	12	27	1246	4676	1.45799192858016
R-HSA-456926	Thrombin signalling through proteinase activated receptors (PARs)	 20	0.826301872790362	1	3	17	1255	4686	0.71077106518283
R-HSA-4570464	SUMOylation of RNA binding proteins	 29	0.414630411524359	1	7	22	1251	4681	1.14376953017927
R-HSA-4608870	Asymmetric localization of PCP proteins	 47	0.994318807696859	1	4	43	1254	4660	0.403274363224301
R-HSA-4615885	SUMOylation of DNA replication proteins	 29	0.595017783486614	1	6	23	1252	4680	0.9803738830108
R-HSA-4641257	Degradation of AXIN	 42	0.996577638394049	1	3	39	1255	4664	0.338462411991824
R-HSA-4641258	Degradation of DVL	 45	0.991891775658168	1	4	41	1254	4662	0.421197668256492
R-HSA-4641262	Disassembly of the destruction complex and recruitment of AXIN to the membrane	 27	0.193438346135847	1	8	19	1250	4684	1.40399222752164
R-HSA-4641263	Regulation of FZD by ubiquitination	 12	0.480543217269381	1	3	9	1255	4694	1.18461844197138
R-HSA-4641265	Repression of WNT target genes	 13	1	1	0	13	1258	4690	0
R-HSA-4791275	Signaling by WNT in cancer	 25	0.437636886758083	1	6	19	1252	4684	1.13723370429253
R-HSA-4839735	AXIN mutants destabilize the destruction complex, activating WNT signaling	 13	0.119008035120833	1	5	8	1253	4695	1.8224899107252
R-HSA-4839743	phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex	 14	0.154445975766771	1	5	9	1253	4694	1.69231205995912
R-HSA-4839744	truncated APC mutants destabilize the destruction complex	 13	0.119008035120833	1	5	8	1253	4695	1.8224899107252
R-HSA-4839748	AMER1 mutants destabilize the destruction complex	 13	0.119008035120833	1	5	8	1253	4695	1.8224899107252
R-HSA-499943	Interconversion of nucleotide di- and triphosphates	 23	0.552202797361461	1	5	18	1253	4685	1.03010299301859
R-HSA-500657	Presynaptic function of Kainate receptors	 14	1	1	0	14	1258	4689	0
R-HSA-5083630	Defective LFNG causes SCDO3	  5	1	1	0	5	1258	4698	0
R-HSA-5083635	Defective B3GALTL causes Peters-plus syndrome (PpS)	 18	0.918744185015892	1	2	16	1256	4687	0.526497085320615
R-HSA-5099900	WNT5A-dependent internalization of FZD4	 12	0.942006117300883	1	1	11	1257	4692	0.394872813990461
R-HSA-512988	Interleukin-3, 5 and GM-CSF signaling	 26	0.668780608122394	1	5	21	1253	4682	0.911244955362602
R-HSA-5140745	WNT5A-dependent internalization of FZD2, FZD5 and ROR2	 11	1	1	0	11	1258	4692	0
R-HSA-5173105	O-linked glycosylation	 58	0.8902372432418	1	9	49	1249	4654	0.7352804122581
R-HSA-5173214	O-glycosylation of TSR domain-containing proteins	 19	0.932983775923062	1	2	17	1256	4686	0.498786712409003
R-HSA-5205647	Mitophagy	 16	0.881342634259459	1	2	14	1256	4689	0.592309220985692
R-HSA-5205685	Pink/Parkin Mediated Mitophagy	 13	0.954269742184979	1	1	12	1257	4691	0.364497982145041
R-HSA-5210891	Uptake and function of anthrax toxins	  7	0.453498803768073	1	2	5	1256	4698	1.3538496479673
R-HSA-5213460	RIPK1-mediated regulated necrosis	 12	0.755417103399376	1	2	10	1256	4693	0.789745627980922
R-HSA-5218859	Regulated Necrosis	 12	0.755417103399376	1	2	10	1256	4693	0.789745627980922
R-HSA-5218900	CASP8 activity is inhibited	  7	0.809900309657012	1	1	6	1257	4697	0.676924823983648
R-HSA-5218920	VEGFR2 mediated vascular permeability	 20	0.418741336951152	1	5	15	1253	4688	1.18461844197138
R-HSA-5218921	VEGFR2 mediated cell proliferation	 17	0.497066833796374	1	4	13	1254	4690	1.11493500420836
R-HSA-5223345	Miscellaneous transport and binding events	 19	0.592287309700289	1	4	15	1254	4688	0.997573424818007
R-HSA-5250913	Positive epigenetic regulation of rRNA expression	 44	0.454334094490096	1	10	34	1248	4669	1.07692585633762
R-HSA-5250924	B-WICH complex positively regulates rRNA expression	 31	0.190589305250759	1	9	22	1249	4681	1.37568593261193
R-HSA-5250941	Negative epigenetic regulation of rRNA expression	 42	0.158079276240341	1	12	30	1246	4673	1.3538496479673
R-HSA-5250955	Toxicity of botulinum toxin type D (BoNT/D)	  5	1	1	0	5	1258	4698	0
R-HSA-5250981	Toxicity of botulinum toxin type F (BoNT/F)	  5	1	1	0	5	1258	4698	0
R-HSA-525793	Myogenesis	 19	0.372319270008444	1	5	14	1253	4689	1.24696678102251
R-HSA-5260271	Diseases of Immune System	 18	0.918744185015892	1	2	16	1256	4687	0.526497085320615
R-HSA-532668	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	 24	0.114068952130215	1	8	16	1250	4687	1.57949125596184
R-HSA-5334118	DNA methylation	 11	0.709604789044377	1	2	9	1256	4694	0.861540685070097
R-HSA-5336415	Uptake and function of diphtheria toxin	  6	0.112803303351911	1	3	3	1255	4700	2.36923688394277
R-HSA-5339562	Uptake and actions of bacterial toxins	 24	0.395993173232745	1	6	18	1252	4685	1.18461844197138
R-HSA-5339716	Misspliced GSK3beta mutants stabilize beta-catenin	 14	0.154445975766771	1	5	9	1253	4694	1.69231205995912
R-HSA-5357769	Caspase activation via extrinsic apoptotic signalling pathway	 19	0.932983775923062	1	2	17	1256	4686	0.498786712409003
R-HSA-5357786	TNFR1-induced proapoptotic signaling	  9	0.881750209110067	1	1	8	1257	4695	0.526497085320615
R-HSA-5357905	Regulation of TNFR1 signaling	 23	0.354215017622652	1	6	17	1252	4686	1.23612359162231
R-HSA-5357956	TNFR1-induced NFkappaB signaling pathway	 21	0.272216071960465	1	6	15	1252	4688	1.3538496479673
R-HSA-5358346	Hedgehog ligand biogenesis	 47	0.951094488620118	1	6	41	1252	4662	0.604911544836451
R-HSA-5358493	Synthesis of diphthamide-EEF2	  6	0.371762497819815	1	2	4	1256	4699	1.57949125596184
R-HSA-5358508	Mismatch Repair	  9	0.881750209110067	1	1	8	1257	4695	0.526497085320615
R-HSA-5358565	Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)	  8	0.850065813595789	1	1	7	1257	4696	0.592309220985692
R-HSA-5358606	Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)	  8	0.850065813595789	1	1	7	1257	4696	0.592309220985692
R-HSA-5358747	S33 mutants of beta-catenin aren't phosphorylated	 14	0.154445975766771	1	5	9	1253	4694	1.69231205995912
R-HSA-5358749	S37 mutants of beta-catenin aren't phosphorylated	 14	0.154445975766771	1	5	9	1253	4694	1.69231205995912
R-HSA-5358751	S45 mutants of beta-catenin aren't phosphorylated	 14	0.154445975766771	1	5	9	1253	4694	1.69231205995912
R-HSA-5358752	T41 mutants of beta-catenin aren't phosphorylated	 14	0.154445975766771	1	5	9	1253	4694	1.69231205995912
R-HSA-5362517	Signaling by Retinoic Acid	 28	0.98900310510335	1	2	26	1256	4677	0.338462411991824
R-HSA-5362768	Hh mutants that don't undergo autocatalytic processing are degraded by ERAD	 42	0.959381636580273	1	5	37	1253	4666	0.564104019986373
R-HSA-5365859	RA biosynthesis pathway	 12	0.942006117300883	1	1	11	1257	4692	0.394872813990461
R-HSA-5368286	Mitochondrial translation initiation	 61	0.857631005701541	1	10	51	1248	4652	0.776798978341891
R-HSA-5368287	Mitochondrial translation	 65	0.905437462084245	1	10	55	1248	4648	0.728995964290082
R-HSA-5387390	Hh mutants abrogate ligand secretion	 43	0.965086890426868	1	5	38	1253	4665	0.550985321847155
R-HSA-5389840	Mitochondrial translation elongation	 60	0.956195492074371	1	8	52	1250	4651	0.631796502384738
R-HSA-539107	Activation of E2F1 target genes at G1/S	 12	0.755417103399376	1	2	10	1256	4693	0.789745627980922
R-HSA-5419276	Mitochondrial translation termination	 60	0.956195492074371	1	8	52	1250	4651	0.631796502384738
R-HSA-5423646	Aflatoxin activation and detoxification	  8	0.850065813595789	1	1	7	1257	4696	0.592309220985692
R-HSA-5467337	APC truncation mutants have impaired AXIN binding	 13	0.119008035120833	1	5	8	1253	4695	1.8224899107252
R-HSA-5467340	AXIN missense mutants destabilize the destruction complex	 13	0.119008035120833	1	5	8	1253	4695	1.8224899107252
R-HSA-5467348	Truncations of AMER1 destabilize the destruction complex	 13	0.119008035120833	1	5	8	1253	4695	1.8224899107252
R-HSA-549127	Organic cation transport	  6	1	1	0	6	1258	4697	0
R-HSA-549132	Organic cation/anion/zwitterion transport	  9	1	1	0	9	1258	4694	0
R-HSA-5576886	Phase 4 - resting membrane potential	  9	0.291270746199599	1	3	6	1255	4697	1.57949125596184
R-HSA-5576891	Cardiac conduction	 89	0.87052711643622	1	15	74	1243	4629	0.79861917436273
R-HSA-5576892	Phase 0 - rapid depolarisation	 29	0.889153549853932	1	4	25	1254	4678	0.653582588673867
R-HSA-5576893	Phase 2 - plateau phase	 14	0.82853459821947	1	2	12	1256	4691	0.676924823983648
R-HSA-5576894	Phase 1 - inactivation of fast Na+ channels	  6	0.758985808815735	1	1	5	1257	4698	0.789745627980922
R-HSA-5578749	Transcriptional regulation by small RNAs	 44	0.601689649944191	1	9	35	1249	4668	0.969233270703859
R-HSA-5578768	Physiological factors	  5	0.694448590316415	1	1	4	1257	4699	0.947694753577107
R-HSA-5578775	Ion homeostasis	 41	0.659652211102814	1	8	33	1250	4670	0.924580247392299
R-HSA-5579029	Metabolic disorders of biological oxidation enzymes	 15	0.85715519636857	1	2	13	1256	4690	0.631796502384738
R-HSA-5601884	PIWI-interacting RNA (piRNA) biogenesis	 15	0.642500710250324	1	3	12	1255	4691	0.947694753577107
R-HSA-5602358	Diseases associated with the TLR signaling cascade	 18	0.918744185015892	1	2	16	1256	4687	0.526497085320615
R-HSA-5602498	MyD88 deficiency (TLR2/4)	  7	0.809900309657012	1	1	6	1257	4697	0.676924823983648
R-HSA-5603027	IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)	  7	0.809900309657012	1	1	6	1257	4697	0.676924823983648
R-HSA-5603029	IkBA variant leads to EDA-ID	  6	0.758985808815735	1	1	5	1257	4698	0.789745627980922
R-HSA-5603041	IRAK4 deficiency (TLR2/4)	  7	0.809900309657012	1	1	6	1257	4697	0.676924823983648
R-HSA-5607761	Dectin-1 mediated noncanonical NF-kB signaling	 49	0.996038476458766	1	4	45	1254	4658	0.386814185133513
R-HSA-5607763	CLEC7A (Dectin-1) induces NFAT activation	 10	0.35569981181152	1	3	7	1255	4696	1.42154213036566
R-HSA-5607764	CLEC7A (Dectin-1) signaling	 73	0.872190911977753	1	12	61	1246	4642	0.77892719472091
R-HSA-5609975	Diseases associated with glycosylation precursor biosynthesis	 11	0.709604789044377	1	2	9	1256	4694	0.861540685070097
R-HSA-5610780	Degradation of GLI1 by the proteasome	 46	0.993208686905036	1	4	42	1254	4661	0.412041197207438
R-HSA-5610783	Degradation of GLI2 by the proteasome	 46	0.993208686905036	1	4	42	1254	4661	0.412041197207438
R-HSA-5610785	GLI3 is processed to GLI3R by the proteasome	 46	0.993208686905036	1	4	42	1254	4661	0.412041197207438
R-HSA-5610787	Hedgehog 'off' state	 91	0.83088017883533	1	16	75	1242	4628	0.833138244902951
R-HSA-5617472	Activation of anterior HOX genes in hindbrain development during early embryogenesis	 45	0.76272208455203	1	8	37	1250	4666	0.842395336512983
R-HSA-5619084	ABC transporter disorders	 51	0.778322021599803	1	9	42	1249	4661	0.83620125315627
R-HSA-5619102	SLC transporter disorders	 33	0.981160065310886	1	3	30	1255	4673	0.430770342535048
R-HSA-5619115	Disorders of transmembrane transporters	 84	0.958564980400178	1	12	72	1246	4631	0.676924823983648
R-HSA-5619507	Activation of HOX genes during differentiation	 45	0.76272208455203	1	8	37	1250	4666	0.842395336512983
R-HSA-5620912	Anchoring of the basal body to the plasma membrane	 72	0.000998596637656221	0.423715563331436	27	45	1231	4658	1.77692766295707
R-HSA-5620916	VxPx cargo-targeting to cilium	 16	0.235752807215477	1	5	11	1253	4692	1.48077305246423
R-HSA-5620920	Cargo trafficking to the periciliary membrane	 38	0.269352916388502	1	10	28	1248	4675	1.24696678102251
R-HSA-5620922	BBSome-mediated cargo-targeting to cilium	 18	0.765272869788419	1	3	15	1255	4688	0.789745627980922
R-HSA-5620924	Intraflagellar transport	 41	0.00662607959879498	0.423715563331436	16	25	1242	4678	1.8491604947846
R-HSA-5621480	Dectin-2 family	  6	1	1	0	6	1258	4697	0
R-HSA-5621481	C-type lectin receptors (CLRs)	 92	0.940869346120847	1	14	78	1244	4625	0.721072095113016
R-HSA-5621575	CD209 (DC-SIGN) signaling	 18	0.918744185015892	1	2	16	1256	4687	0.526497085320615
R-HSA-5625740	RHO GTPases activate PKNs	 32	0.526996626558664	1	7	25	1251	4678	1.03654113672496
R-HSA-5625886	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	 13	0.538576769291448	1	3	10	1255	4693	1.09349394643512
R-HSA-5625900	RHO GTPases activate CIT	 12	0.942006117300883	1	1	11	1257	4692	0.394872813990461
R-HSA-5625970	RHO GTPases activate KTN1	  8	0.227769868815571	1	3	5	1255	4698	1.77692766295707
R-HSA-5626467	RHO GTPases activate IQGAPs	 20	0.826301872790362	1	3	17	1255	4686	0.71077106518283
R-HSA-5627117	RHO GTPases Activate ROCKs	 13	0.954269742184979	1	1	12	1257	4691	0.364497982145041
R-HSA-5627123	RHO GTPases activate PAKs	 17	0.901691816657284	1	2	15	1256	4688	0.55746750210418
R-HSA-5628897	TP53 Regulates Metabolic Genes	 65	0.28613272300173	1	16	49	1242	4654	1.16639354286413
R-HSA-5632681	Ligand-receptor interactions	  5	0.694448590316415	1	1	4	1257	4699	0.947694753577107
R-HSA-5632684	Hedgehog 'on' state	 64	0.944451047705768	1	9	55	1249	4648	0.666347873608903
R-HSA-5633008	TP53 Regulates Transcription of Cell Death Genes	 32	0.695958927808585	1	6	26	1252	4677	0.888463831478537
R-HSA-5635838	Activation of SMO	 10	0.906743192466844	1	1	9	1257	4694	0.473847376788553
R-HSA-5635851	GLI proteins bind promoters of Hh responsive genes to promote transcription	  6	0.758985808815735	1	1	5	1257	4698	0.789745627980922
R-HSA-5637810	Constitutive Signaling by EGFRvIII	 14	0.592690741525265	1	3	11	1255	4692	1.01538723597547
R-HSA-5637812	Signaling by EGFRvIII in Cancer	 14	0.592690741525265	1	3	11	1255	4692	1.01538723597547
R-HSA-5637815	Signaling by Ligand-Responsive EGFR Variants in Cancer	 15	0.642500710250324	1	3	12	1255	4691	0.947694753577107
R-HSA-5649702	APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway	  5	0.694448590316415	1	1	4	1257	4699	0.947694753577107
R-HSA-5651801	PCNA-Dependent Long Patch Base Excision Repair	 15	0.85715519636857	1	2	13	1256	4690	0.631796502384738
R-HSA-5654219	Phospholipase C-mediated cascade: FGFR1	  5	0.0666681617559274	1	3	2	1255	4701	2.84308426073132
R-HSA-5654221	Phospholipase C-mediated cascade; FGFR2	  5	0.0666681617559274	1	3	2	1255	4701	2.84308426073132
R-HSA-5654227	Phospholipase C-mediated cascade; FGFR3	  5	0.285442766330515	1	2	3	1256	4700	1.89538950715421
R-HSA-5654687	Downstream signaling of activated FGFR1	 18	0.0657327901282507	1	7	11	1251	4692	1.84273979862215
R-HSA-5654688	SHC-mediated cascade:FGFR1	 10	0.140936259771786	1	4	6	1254	4697	1.89538950715421
R-HSA-5654689	PI-3K cascade:FGFR1	 10	0.00835059869339327	0.423715563331436	6	4	1252	4699	2.84308426073132
R-HSA-5654693	FRS-mediated FGFR1 signaling	 11	0.0151230935429888	0.578684096835011	6	5	1252	4698	2.58462205521029
R-HSA-5654695	PI-3K cascade:FGFR2	 10	0.00835059869339327	0.423715563331436	6	4	1252	4699	2.84308426073132
R-HSA-5654696	Downstream signaling of activated FGFR2	 16	0.0348653428939975	0.86846399572321	7	9	1251	4694	2.07308227344992
R-HSA-5654699	SHC-mediated cascade:FGFR2	 10	0.140936259771786	1	4	6	1254	4697	1.89538950715421
R-HSA-5654700	FRS-mediated FGFR2 signaling	 11	0.0151230935429888	0.578684096835011	6	5	1252	4698	2.58462205521029
R-HSA-5654704	SHC-mediated cascade:FGFR3	 10	0.35569981181152	1	3	7	1255	4696	1.42154213036566
R-HSA-5654706	FRS-mediated FGFR3 signaling	 11	0.0616765637262025	1	5	6	1253	4697	2.15385171267524
R-HSA-5654708	Downstream signaling of activated FGFR3	 16	0.100882651035028	1	6	10	1252	4693	1.77692766295707
R-HSA-5654710	PI-3K cascade:FGFR3	 10	0.0405158954611054	0.895270593253458	5	5	1253	4698	2.36923688394277
R-HSA-5654712	FRS-mediated FGFR4 signaling	 10	0.0405158954611054	0.895270593253458	5	5	1253	4698	2.36923688394277
R-HSA-5654716	Downstream signaling of activated FGFR4	 15	0.0761261604821413	1	6	9	1252	4694	1.89538950715421
R-HSA-5654719	SHC-mediated cascade:FGFR4	  9	0.291270746199599	1	3	6	1255	4697	1.57949125596184
R-HSA-5654720	PI-3K cascade:FGFR4	  9	0.0244332470772493	0.743856633240702	5	4	1253	4699	2.63248542660307
R-HSA-5654726	Negative regulation of FGFR1 signaling	 17	0.0150038338725942	0.578684096835011	8	9	1250	4694	2.22987000841672
R-HSA-5654727	Negative regulation of FGFR2 signaling	 16	0.0348653428939975	0.86846399572321	7	9	1251	4694	2.07308227344992
R-HSA-5654732	Negative regulation of FGFR3 signaling	 16	0.100882651035028	1	6	10	1252	4693	1.77692766295707
R-HSA-5654733	Negative regulation of FGFR4 signaling	 15	0.0761261604821413	1	6	9	1252	4694	1.89538950715421
R-HSA-5654736	Signaling by FGFR1	 30	0.0365238595510512	0.877854168156845	11	19	1247	4684	1.73744038155803
R-HSA-5654738	Signaling by FGFR2	 44	0.0314140347430466	0.832120089163637	15	29	1243	4674	1.61538878450643
R-HSA-5654741	Signaling by FGFR3	 25	0.138261188937754	1	8	17	1250	4686	1.51631160572337
R-HSA-5654743	Signaling by FGFR4	 24	0.114068952130215	1	8	16	1250	4687	1.57949125596184
R-HSA-5655253	Signaling by FGFR2 in disease	 24	0.114068952130215	1	8	16	1250	4687	1.57949125596184
R-HSA-5655291	Signaling by FGFR4 in disease	 10	0.35569981181152	1	3	7	1255	4696	1.42154213036566
R-HSA-5655302	Signaling by FGFR1 in disease	 28	0.0216316821457384	0.721209446464984	11	17	1247	4686	1.86154326595503
R-HSA-5655332	Signaling by FGFR3 in disease	 14	0.154445975766771	1	5	9	1253	4694	1.69231205995912
R-HSA-5655862	Translesion synthesis by POLK	 14	0.154445975766771	1	5	9	1253	4694	1.69231205995912
R-HSA-5656121	Translesion synthesis by POLI	 14	0.154445975766771	1	5	9	1253	4694	1.69231205995912
R-HSA-5656169	Termination of translesion DNA synthesis	 19	0.372319270008444	1	5	14	1253	4689	1.24696678102251
R-HSA-5658442	Regulation of RAS by GAPs	 54	0.908920873272381	1	8	46	1250	4657	0.70199611376082
R-HSA-5660526	Response to metal ions	  9	1	1	0	9	1258	4694	0
R-HSA-5661231	Metallothioneins bind metals	  7	1	1	0	7	1258	4696	0
R-HSA-5663084	Diseases of carbohydrate metabolism	 19	0.932983775923062	1	2	17	1256	4686	0.498786712409003
R-HSA-5663213	RHO GTPases Activate WASPs and WAVEs	 29	0.763456111655678	1	5	24	1253	4679	0.816978235842333
R-HSA-5663220	RHO GTPases Activate Formins	 79	0.929197459482007	1	12	67	1246	4636	0.719768167273752
R-HSA-5666185	RHO GTPases Activate Rhotekin and Rhophilins	  6	0.758985808815735	1	1	5	1257	4698	0.789745627980922
R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	 63	0.995711068901438	1	6	57	1252	4646	0.451283215989098
R-HSA-5668599	RHO GTPases Activate NADPH Oxidases	  6	1	1	0	6	1258	4697	0
R-HSA-5668914	Diseases of metabolism	 52	0.683556477624897	1	10	42	1248	4661	0.911244955362602
R-HSA-5669034	TNFs bind their physiological receptors	  7	0.809900309657012	1	1	6	1257	4697	0.676924823983648
R-HSA-5673000	RAF activation	 22	0.164036518152948	1	7	15	1251	4688	1.50769619887267
R-HSA-5674135	MAP2K and MAPK activation	 26	0.934685183899572	1	3	23	1255	4680	0.546746973217561
R-HSA-5674400	Constitutive Signaling by AKT1 E17K in Cancer	 20	0.635673802887573	1	4	16	1254	4687	0.947694753577107
R-HSA-5674499	Negative feedback regulation of MAPK pathway	  5	0.694448590316415	1	1	4	1257	4699	0.947694753577107
R-HSA-5675221	Negative regulation of MAPK pathway	 34	0.429970480702057	1	8	26	1250	4677	1.11493500420836
R-HSA-5675482	Regulation of necroptotic cell death	 11	0.709604789044377	1	2	9	1256	4694	0.861540685070097
R-HSA-5676590	NIK-->noncanonical NF-kB signaling	 47	0.994318807696859	1	4	43	1254	4660	0.403274363224301
R-HSA-5676594	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	 11	0.709604789044377	1	2	9	1256	4694	0.861540685070097
R-HSA-5676934	Protein repair	  6	0.758985808815735	1	1	5	1257	4698	0.789745627980922
R-HSA-5678895	Defective CFTR causes cystic fibrosis	 45	0.935650462433703	1	6	39	1252	4664	0.631796502384738
R-HSA-5682910	LGI-ADAM interactions	 13	0.954269742184979	1	1	12	1257	4691	0.364497982145041
R-HSA-5683826	Surfactant metabolism	 12	0.942006117300883	1	1	11	1257	4692	0.394872813990461
R-HSA-5684264	MAP3K8 (TPL2)-dependent MAPK1/3 activation	 11	0.709604789044377	1	2	9	1256	4694	0.861540685070097
R-HSA-5685938	HDR through Single Strand Annealing (SSA)	 22	0.509161975679111	1	5	17	1253	4686	1.07692585633762
R-HSA-5685942	HDR through Homologous Recombination (HRR)	 31	0.323951773629733	1	8	23	1250	4680	1.22283194009949
R-HSA-5686938	Regulation of TLR by endogenous ligand	 10	0.656813358899076	1	2	8	1256	4695	0.947694753577107
R-HSA-5687128	MAPK6/MAPK4 signaling	 68	0.87754303515574	1	11	57	1247	4646	0.766517815393248
R-HSA-5689603	UCH proteinases	 67	0.961410480897834	1	9	58	1249	4645	0.636511401656266
R-HSA-5689877	Josephin domain DUBs	  5	0.694448590316415	1	1	4	1257	4699	0.947694753577107
R-HSA-5689896	Ovarian tumor domain proteases	 23	0.969553696859762	1	2	21	1256	4682	0.412041197207438
R-HSA-5689901	Metalloprotease DUBs	 13	0.794842618691727	1	2	11	1256	4692	0.728995964290082
R-HSA-5690714	CD22 mediated BCR regulation	  7	1	1	0	7	1258	4696	0
R-HSA-5693532	DNA Double-Strand Break Repair	 77	0.776991466956096	1	14	63	1244	4640	0.861540685070097
R-HSA-5693537	Resolution of D-Loop Structures	 12	0.235378041172751	1	4	8	1254	4695	1.57949125596184
R-HSA-5693538	Homology Directed Repair	 58	0.810495410837637	1	10	48	1248	4655	0.816978235842333
R-HSA-5693554	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	 10	0.35569981181152	1	3	7	1255	4696	1.42154213036566
R-HSA-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	 32	0.929430767029959	1	4	28	1254	4675	0.592309220985692
R-HSA-5693567	HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)	 56	0.773117875198095	1	10	46	1248	4657	0.846156029979559
R-HSA-5693568	Resolution of D-loop Structures through Holliday Junction Intermediates	 12	0.235378041172751	1	4	8	1254	4695	1.57949125596184
R-HSA-5693571	Nonhomologous End-Joining (NHEJ)	 28	0.871815972171414	1	4	24	1254	4679	0.676924823983648
R-HSA-5693579	Homologous DNA Pairing and Strand Exchange	 22	0.509161975679111	1	5	17	1253	4686	1.07692585633762
R-HSA-5693606	DNA Double Strand Break Response	 32	0.929430767029959	1	4	28	1254	4675	0.592309220985692
R-HSA-5693607	Processing of DNA double-strand break ends	 40	0.945337830578547	1	5	35	1253	4668	0.592309220985692
R-HSA-5693616	Presynaptic phase of homologous DNA pairing and strand exchange	 21	0.464530482260742	1	5	16	1253	4687	1.12820803997275
R-HSA-5694530	Cargo concentration in the ER	 24	0.395993173232745	1	6	18	1252	4685	1.18461844197138
R-HSA-5696394	DNA Damage Recognition in GG-NER	 25	0.997366509544105	1	1	24	1257	4679	0.189538950715421
R-HSA-5696395	Formation of Incision Complex in GG-NER	 30	0.28953565275774	1	8	22	1250	4681	1.26359300476948
R-HSA-5696397	Gap-filling DNA repair synthesis and ligation in GG-NER	 14	0.592690741525265	1	3	11	1255	4692	1.01538723597547
R-HSA-5696398	Nucleotide Excision Repair	 72	0.453874437144915	1	16	56	1242	4647	1.05299417064123
R-HSA-5696399	Global Genome Nucleotide Excision Repair (GG-NER)	 56	0.658088613710923	1	11	45	1247	4658	0.930771632977515
R-HSA-5696400	Dual Incision in GG-NER	 27	0.193438346135847	1	8	19	1250	4684	1.40399222752164
R-HSA-606279	Deposition of new CENPA-containing nucleosomes at the centromere	 20	0.635673802887573	1	4	16	1254	4687	0.947694753577107
R-HSA-611105	Respiratory electron transport	 55	0.632772721530589	1	11	44	1247	4659	0.947694753577107
R-HSA-622312	Inflammasomes	 12	0.942006117300883	1	1	11	1257	4692	0.394872813990461
R-HSA-674695	RNA Polymerase II Pre-transcription Events	 53	0.020270892942373	0.694278083276276	18	35	1240	4668	1.60929297777245
R-HSA-6781823	Formation of TC-NER Pre-Incision Complex	 35	0.187201000096241	1	10	25	1248	4678	1.3538496479673
R-HSA-6781827	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	 50	0.24332064229595	1	13	37	1245	4666	1.23200317965024
R-HSA-6782135	Dual incision in TC-NER	 43	0.102513292676227	1	13	30	1245	4673	1.4325618368026
R-HSA-6782210	Gap-filling DNA repair synthesis and ligation in TC-NER	 40	0.119333653894555	1	12	28	1246	4675	1.42154213036566
R-HSA-6782315	tRNA modification in the nucleus and cytosol	 30	0.0365238595510512	0.877854168156845	11	19	1247	4684	1.73744038155803
R-HSA-6782861	Synthesis of wybutosine at G37 of tRNA(Phe)	  5	0.285442766330515	1	2	3	1256	4700	1.89538950715421
R-HSA-6783310	Fanconi Anemia Pathway	 22	0.713005229244882	1	4	18	1254	4685	0.861540685070097
R-HSA-6783589	Interleukin-6 family signaling	 19	0.0858228764970588	1	7	12	1251	4691	1.74575349343151
R-HSA-6783783	Interleukin-10 signaling	 24	0.996658467015036	1	1	23	1257	4680	0.197436406995231
R-HSA-6784531	tRNA processing in the nucleus	 43	0.42297810962534	1	10	33	1248	4670	1.10197064369431
R-HSA-6785631	ERBB2 Regulates Cell Motility	 10	0.656813358899076	1	2	8	1256	4695	0.947694753577107
R-HSA-6785807	Interleukin-4 and 13 signaling	 66	0.956356479171939	1	9	57	1249	4646	0.646155513802573
R-HSA-6787450	tRNA modification in the mitochondrion	  6	0.112803303351911	1	3	3	1255	4700	2.36923688394277
R-HSA-6788467	IL-6-type cytokine receptor ligand interactions	 12	0.235378041172751	1	4	8	1254	4695	1.57949125596184
R-HSA-6788656	Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism	 26	0.830064425387061	1	4	22	1254	4681	0.728995964290082
R-HSA-6790901	rRNA modification in the nucleus and cytosol	 30	0.452702729409852	1	7	23	1251	4680	1.10564387917329
R-HSA-6791226	Major pathway of rRNA processing in the nucleolus and cytosol	 76	0.437796437046343	1	17	59	1241	4644	1.05992176386913
R-HSA-6791312	TP53 Regulates Transcription of Cell Cycle Genes	 30	0.452702729409852	1	7	23	1251	4680	1.10564387917329
R-HSA-6794361	Neurexins and neuroligins	 48	0.823907486865944	1	8	40	1250	4663	0.789745627980922
R-HSA-6794362	Protein-protein interactions at synapses	 74	0.933924639529616	1	11	63	1247	4640	0.704367722253255
R-HSA-6796648	TP53 Regulates Transcription of DNA Repair Genes	 34	0.0397323016890379	0.895270593253458	12	22	1246	4681	1.67240250631254
R-HSA-6798163	Choline catabolism	  5	0.285442766330515	1	2	3	1256	4700	1.89538950715421
R-HSA-6799198	Complex I biogenesis	 30	0.904403630664436	1	4	26	1254	4677	0.631796502384738
R-HSA-6802946	Signaling by moderate kinase activity BRAF mutants	 27	0.852187264802933	1	4	23	1254	4680	0.70199611376082
R-HSA-6802948	Signaling by high-kinase activity BRAF mutants	 24	0.97510129524537	1	2	22	1256	4681	0.394872813990461
R-HSA-6802949	Signaling by RAS mutants	 38	0.56726627761331	1	8	30	1250	4673	0.997573424818007
R-HSA-6802952	Signaling by BRAF and RAF fusions	 45	0.76272208455203	1	8	37	1250	4666	0.842395336512983
R-HSA-6802955	Paradoxical activation of RAF signaling by kinase inactive BRAF	 27	0.852187264802933	1	4	23	1254	4680	0.70199611376082
R-HSA-6802957	Oncogenic MAPK signaling	 58	0.454428684018848	1	13	45	1245	4658	1.06207170659503
R-HSA-6803157	Antimicrobial peptides	 23	1	1	0	23	1258	4680	0
R-HSA-6803204	TP53 Regulates Transcription of Genes Involved in Cytochrome C Release	 15	0.642500710250324	1	3	12	1255	4691	0.947694753577107
R-HSA-6803205	TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain	  9	0.881750209110067	1	1	8	1257	4695	0.526497085320615
R-HSA-6803207	TP53 Regulates Transcription of Caspase Activators and Caspases	  8	0.0668415065051738	1	4	4	1254	4699	2.36923688394277
R-HSA-6803211	TP53 Regulates Transcription of Death Receptors and Ligands	  8	0.850065813595789	1	1	7	1257	4696	0.592309220985692
R-HSA-6803529	FGFR2 alternative splicing	 19	0.0858228764970588	1	7	12	1251	4691	1.74575349343151
R-HSA-6804114	TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest	 10	0.656813358899076	1	2	8	1256	4695	0.947694753577107
R-HSA-6804115	TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain	 14	0.34015887110078	1	4	10	1254	4693	1.3538496479673
R-HSA-6804116	TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest	  7	0.809900309657012	1	1	6	1257	4697	0.676924823983648
R-HSA-6804756	Regulation of TP53 Activity through Phosphorylation	 54	0.606515800752556	1	11	43	1247	4660	0.965244656421127
R-HSA-6804757	Regulation of TP53 Degradation	 25	0.0626604489141934	1	9	16	1249	4687	1.70585055643879
R-HSA-6804758	Regulation of TP53 Activity through Acetylation	 25	0.922613557917359	1	3	22	1255	4681	0.568616852146264
R-HSA-6804759	Regulation of TP53 Activity through Association with Co-factors	 10	0.656813358899076	1	2	8	1256	4695	0.947694753577107
R-HSA-6804760	Regulation of TP53 Activity through Methylation	 11	0.186227514654976	1	4	7	1254	4696	1.72308137014019
R-HSA-6805567	Keratinization	 22	1	1	0	22	1258	4681	0
R-HSA-6806003	Regulation of TP53 Expression and Degradation	 25	0.0626604489141934	1	9	16	1249	4687	1.70585055643879
R-HSA-6806667	Metabolism of fat-soluble vitamins	 24	0.908530114618068	1	3	21	1255	4682	0.592309220985692
R-HSA-6806834	Signaling by MET	 57	0.307464706339963	1	14	43	1244	4660	1.16383566228767
R-HSA-6807004	Negative regulation of MET activity	 15	0.0761261604821413	1	6	9	1252	4694	1.89538950715421
R-HSA-6807070	PTEN Regulation	 99	0.91334185591935	1	16	83	1242	4620	0.76581394228453
R-HSA-6807505	RNA polymerase II transcribes snRNA genes	 51	0.171553382339251	1	14	37	1244	4666	1.30075750490975
R-HSA-6807878	COPI-mediated anterograde transport	 71	0.846505612477413	1	12	59	1246	4644	0.800868805839808
R-HSA-6809371	Formation of the cornified envelope	 21	1	1	0	21	1258	4682	0
R-HSA-6811434	COPI-dependent Golgi-to-ER retrograde traffic	 61	0.961468281613143	1	8	53	1250	4650	0.621439182673513
R-HSA-6811436	COPI-independent Golgi-to-ER retrograde traffic	 37	0.691128405087543	1	7	30	1251	4673	0.896468010140506
R-HSA-6811438	Intra-Golgi traffic	 32	0.0032315618622567	0.423715563331436	14	18	1244	4685	2.07308227344992
R-HSA-6811440	Retrograde transport at the Trans-Golgi-Network	 33	0.0315841201726344	0.832120089163637	12	21	1246	4682	1.72308137014019
R-HSA-6811555	PI5P Regulates TP53 Acetylation	  7	1	1	0	7	1258	4696	0
R-HSA-6811558	PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling	 55	0.258771721479937	1	14	41	1244	4662	1.20615695909814
R-HSA-6814122	Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding	 28	0.95377919798048	1	3	25	1255	4678	0.507693617987736
R-HSA-6814848	Glycerophospholipid catabolism	  5	1	1	0	5	1258	4698	0
R-HSA-68616	Assembly of the ORC complex at the origin of replication	  5	1	1	0	5	1258	4698	0
R-HSA-68689	CDC6 association with the ORC:origin complex	  6	1	1	0	6	1258	4697	0
R-HSA-68827	CDT1 association with the CDC6:ORC:origin complex	 44	0.997685765411721	1	3	41	1255	4662	0.323077756901286
R-HSA-68867	Assembly of the pre-replicative complex	 49	0.999143233184133	1	3	46	1255	4657	0.290110638850135
R-HSA-68874	M/G1 Transition	 58	0.999863240119068	1	3	55	1255	4648	0.2450934707527
R-HSA-68875	Mitotic Prophase	 69	0.18966404185206	1	18	51	1240	4652	1.23612359162231
R-HSA-68884	Mitotic Telophase/Cytokinesis	 10	0.140936259771786	1	4	6	1254	4697	1.89538950715421
R-HSA-68949	Orc1 removal from chromatin	 52	0.997712345673983	1	4	48	1254	4655	0.364497982145041
R-HSA-68962	Activation of the pre-replicative complex	 20	1	1	0	20	1258	4683	0
R-HSA-69002	DNA Replication Pre-Initiation	 58	0.999863240119068	1	3	55	1255	4648	0.2450934707527
R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6	 38	0.9926072579238	1	3	35	1255	4668	0.374090034306753
R-HSA-69052	Switching of origins to a post-replicative state	 52	0.997712345673983	1	4	48	1254	4655	0.364497982145041
R-HSA-69091	Polymerase switching	  9	0.596590649481565	1	2	7	1256	4696	1.05299417064123
R-HSA-69109	Leading Strand Synthesis	  9	0.596590649481565	1	2	7	1256	4696	1.05299417064123
R-HSA-69166	Removal of the Flap Intermediate	  9	1	1	0	9	1258	4694	0
R-HSA-69183	Processive synthesis on the lagging strand	  9	1	1	0	9	1258	4694	0
R-HSA-69186	Lagging Strand Synthesis	 14	0.82853459821947	1	2	12	1256	4691	0.676924823983648
R-HSA-69190	DNA strand elongation	 20	0.944837320715584	1	2	18	1256	4685	0.473847376788553
R-HSA-69202	Cyclin E associated events during G1/S transition 	 58	0.974857912450111	1	7	51	1251	4652	0.571884765089633
R-HSA-69205	G1/S-Specific Transcription	 12	0.755417103399376	1	2	10	1256	4693	0.789745627980922
R-HSA-69206	G1/S Transition	 88	0.997881591395372	1	9	79	1249	4624	0.484616635351929
R-HSA-69229	Ubiquitin-dependent degradation of Cyclin D1	 38	0.9926072579238	1	3	35	1255	4668	0.374090034306753
R-HSA-69231	Cyclin D associated events in G1	 28	0.223970936590072	1	8	20	1250	4683	1.3538496479673
R-HSA-69236	G1 Phase	 28	0.223970936590072	1	8	20	1250	4683	1.3538496479673
R-HSA-69239	Synthesis of DNA	 69	0.998419637634896	1	6	63	1252	4640	0.412041197207438
R-HSA-69242	S Phase	 94	0.987214392968404	1	12	82	1246	4621	0.604911544836451
R-HSA-69273	Cyclin A/B1/B2 associated events during G2/M transition	 15	0.642500710250324	1	3	12	1255	4691	0.947694753577107
R-HSA-69298	Association of licensing factors with the pre-replicative complex	  7	1	1	0	7	1258	4696	0
R-HSA-69300	Removal of licensing factors from origins	 53	0.998098909926612	1	4	49	1254	4654	0.35762066172721
R-HSA-69304	Regulation of DNA replication	 53	0.998098909926612	1	4	49	1254	4654	0.35762066172721
R-HSA-69306	DNA Replication	 72	0.999053828867102	1	6	66	1252	4637	0.394872813990461
R-HSA-69416	Dimerization of procaspase-8	  7	0.809900309657012	1	1	6	1257	4697	0.676924823983648
R-HSA-69473	G2/M DNA damage checkpoint	 41	0.983746281254152	1	4	37	1254	4666	0.462290123696149
R-HSA-69481	G2/M Checkpoints	 90	0.999848619286588	1	7	83	1251	4620	0.36854795972443
R-HSA-69541	Stabilization of p53	 41	0.952833573052402	1	5	36	1253	4667	0.577862654620187
R-HSA-69563	p53-Dependent G1 DNA Damage Response	 47	0.951094488620118	1	6	41	1252	4662	0.604911544836451
R-HSA-69580	p53-Dependent G1/S DNA damage checkpoint	 47	0.951094488620118	1	6	41	1252	4662	0.604911544836451
R-HSA-69601	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	 38	0.973046501812794	1	4	34	1254	4669	0.498786712409003
R-HSA-69610	p53-Independent DNA Damage Response	 38	0.973046501812794	1	4	34	1254	4669	0.498786712409003
R-HSA-69613	p53-Independent G1/S DNA damage checkpoint	 38	0.973046501812794	1	4	34	1254	4669	0.498786712409003
R-HSA-69615	G1/S DNA Damage Checkpoints	 47	0.951094488620118	1	6	41	1252	4662	0.604911544836451
R-HSA-69618	Mitotic Spindle Checkpoint	 60	0.911874895788105	1	9	51	1249	4652	0.71077106518283
R-HSA-69656	Cyclin A:Cdk2-associated events at S phase entry	 56	0.966822678835417	1	7	49	1251	4654	0.592309220985691
R-HSA-70171	Glycolysis	 49	0.841346321793507	1	8	41	1250	4662	0.773628370267026
R-HSA-70221	Glycogen breakdown (glycogenolysis)	 13	0.538576769291448	1	3	10	1255	4693	1.09349394643512
R-HSA-70263	Gluconeogenesis	 22	0.962823796383355	1	2	20	1256	4683	0.430770342535048
R-HSA-70268	Pyruvate metabolism	 22	0.873207475913891	1	3	19	1255	4684	0.646155513802573
R-HSA-70326	Glucose metabolism	 64	0.894953819992747	1	10	54	1248	4649	0.740386526232115
R-HSA-70370	Galactose catabolism	  5	0.285442766330515	1	2	3	1256	4700	1.89538950715421
R-HSA-70614	Amino acid synthesis and interconversion (transamination)	 23	0.552202797361461	1	5	18	1253	4685	1.03010299301859
R-HSA-70635	Urea cycle	  5	1	1	0	5	1258	4698	0
R-HSA-70895	Branched-chain amino acid catabolism	 18	0.0002574042318052	0.258330616522886	11	7	1247	4696	2.89573396926338
R-HSA-71064	Lysine catabolism	 10	0.656813358899076	1	2	8	1256	4695	0.947694753577107
R-HSA-71182	Phenylalanine and tyrosine catabolism	  7	0.809900309657012	1	1	6	1257	4697	0.676924823983648
R-HSA-71240	Tryptophan catabolism	  5	0.285442766330515	1	2	3	1256	4700	1.89538950715421
R-HSA-71288	Creatine metabolism	  7	1	1	0	7	1258	4696	0
R-HSA-71336	Pentose phosphate pathway (hexose monophosphate shunt)	 11	0.709604789044377	1	2	9	1256	4694	0.861540685070097
R-HSA-71384	Ethanol oxidation	  5	1	1	0	5	1258	4698	0
R-HSA-71403	Citric acid cycle (TCA cycle)	 15	1	1	0	15	1258	4688	0
R-HSA-71406	Pyruvate metabolism and Citric Acid (TCA) cycle	 38	0.973046501812794	1	4	34	1254	4669	0.498786712409003
R-HSA-72086	mRNA Capping	 17	0.129308606576508	1	6	11	1252	4692	1.67240250631254
R-HSA-72165	mRNA Splicing - Minor Pathway	 32	0.218701124049026	1	9	23	1249	4680	1.33269574721781
R-HSA-72187	mRNA 3'-end processing	 42	0.000377124987624651	0.258330616522886	19	23	1239	4680	2.14359527594822
R-HSA-72202	Transport of Mature Transcript to Cytoplasm	 57	0.00448902874660218	0.423715563331436	21	36	1237	4667	1.74575349343151
R-HSA-72306	tRNA processing	 78	0.0497578446218081	1	23	55	1235	4648	1.39724226488932
R-HSA-72312	rRNA processing	 85	0.430601578146784	1	19	66	1239	4637	1.05918825399794
R-HSA-72613	Eukaryotic Translation Initiation	 39	0.29896128163228	1	10	29	1248	4674	1.2149932738168
R-HSA-72649	Translation initiation complex formation	 21	0.67594281950565	1	4	17	1254	4686	0.902566431978197
R-HSA-72662	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	 22	0.713005229244882	1	4	18	1254	4685	0.861540685070097
R-HSA-72689	Formation of a pool of free 40S subunits	 26	0.300718679946055	1	7	19	1251	4684	1.27574293750764
R-HSA-72695	Formation of the ternary complex, and subsequently, the 43S complex	 19	0.592287309700289	1	4	15	1254	4688	0.997573424818007
R-HSA-72702	Ribosomal scanning and start codon recognition	 21	0.464530482260742	1	5	16	1253	4687	1.12820803997275
R-HSA-72706	GTP hydrolysis and joining of the 60S ribosomal subunit	 32	0.218701124049026	1	9	23	1249	4680	1.33269574721781
R-HSA-72731	Recycling of eIF2:GDP	  8	0.528741782085573	1	2	6	1256	4697	1.18461844197138
R-HSA-72737	Cap-dependent Translation Initiation	 39	0.29896128163228	1	10	29	1248	4674	1.2149932738168
R-HSA-72764	Eukaryotic Translation Termination	 20	0.109003485304835	1	7	13	1251	4690	1.65846581875994
R-HSA-727802	Transport of nucleotide sugars	  6	0.758985808815735	1	1	5	1257	4698	0.789745627980922
R-HSA-73728	RNA Polymerase I Promoter Opening	 11	0.709604789044377	1	2	9	1256	4694	0.861540685070097
R-HSA-73762	RNA Polymerase I Transcription Initiation	 33	0.394474620190751	1	8	25	1250	4678	1.1487209134268
R-HSA-73772	RNA Polymerase I Promoter Escape	 19	0.195838194017673	1	6	13	1252	4690	1.49636013722701
R-HSA-73776	RNA Polymerase II Promoter Escape	 31	0.323951773629733	1	8	23	1250	4680	1.22283194009949
R-HSA-73777	RNA Polymerase I Chain Elongation	 29	0.256104004986529	1	8	21	1250	4682	1.30716517734773
R-HSA-73779	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	 31	0.323951773629733	1	8	23	1250	4680	1.22283194009949
R-HSA-73780	RNA Polymerase III Chain Elongation	 14	0.82853459821947	1	2	12	1256	4691	0.676924823983648
R-HSA-73817	Purine ribonucleoside monophosphate biosynthesis	  9	0.881750209110067	1	1	8	1257	4695	0.526497085320615
R-HSA-73854	RNA Polymerase I Promoter Clearance	 43	0.42297810962534	1	10	33	1248	4670	1.10197064369431
R-HSA-73856	RNA Polymerase II Transcription Termination	 47	0.00199247576505844	0.423715563331436	19	28	1239	4675	1.91555322531543
R-HSA-73863	RNA Polymerase I Transcription Termination	 20	0.233053069180318	1	6	14	1252	4689	1.42154213036566
R-HSA-73864	RNA Polymerase I Transcription	 45	0.485438892320443	1	10	35	1248	4668	1.05299417064123
R-HSA-73884	Base Excision Repair	 24	0.908530114618068	1	3	21	1255	4682	0.592309220985692
R-HSA-73886	Chromosome Maintenance	 41	0.792376510959752	1	7	34	1251	4669	0.809007716468262
R-HSA-73887	Death Receptor Signalling	 36	0.11939917272342	1	11	25	1247	4678	1.44786698463169
R-HSA-73893	DNA Damage Bypass	 31	0.323951773629733	1	8	23	1250	4680	1.22283194009949
R-HSA-73928	Depyrimidination	  5	0.694448590316415	1	1	4	1257	4699	0.947694753577107
R-HSA-73929	Base-Excision Repair, AP Site Formation	  5	0.694448590316415	1	1	4	1257	4699	0.947694753577107
R-HSA-73933	Resolution of Abasic Sites (AP sites)	 24	0.908530114618068	1	3	21	1255	4682	0.592309220985692
R-HSA-73942	DNA Damage Reversal	  6	1	1	0	6	1258	4697	0
R-HSA-73943	Reversal of alkylation damage by DNA dioxygenases	  6	1	1	0	6	1258	4697	0
R-HSA-73980	RNA Polymerase III Transcription Termination	 19	0.797707662304944	1	3	16	1255	4687	0.748180068613505
R-HSA-74158	RNA Polymerase III Transcription	 33	0.72557743881647	1	6	27	1252	4676	0.861540685070097
R-HSA-74182	Ketone body metabolism	  7	0.167421732949172	1	3	4	1255	4699	2.03077447195094
R-HSA-74217	Purine salvage	 10	0.656813358899076	1	2	8	1256	4695	0.947694753577107
R-HSA-74259	Purine catabolism	  9	0.291270746199599	1	3	6	1255	4697	1.57949125596184
R-HSA-74749	Signal attenuation	  7	0.167421732949172	1	3	4	1255	4699	2.03077447195094
R-HSA-74751	Insulin receptor signalling cascade	 26	0.0117545961856297	0.575135599082594	11	15	1247	4688	2.00473890179773
R-HSA-74752	Signaling by Insulin receptor	 41	0.0742954908033678	1	13	28	1245	4675	1.50244290201249
R-HSA-749476	RNA Polymerase III Abortive And Retractive Initiation	 33	0.72557743881647	1	6	27	1252	4676	0.861540685070097
R-HSA-75035	Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex	  7	1	1	0	7	1258	4696	0
R-HSA-75067	Processing of Capped Intronless Pre-mRNA	 22	0.312783404638284	1	6	16	1252	4687	1.29231102760515
R-HSA-75105	Fatty acyl-CoA biosynthesis	 24	0.00574883126544544	0.423715563331436	11	13	1247	4690	2.17180047694754
R-HSA-75153	Apoptotic execution  phase	 36	0.0273330319464656	0.814048994927347	13	23	1245	4680	1.711115527292
R-HSA-75158	TRAIL  signaling	  5	0.694448590316415	1	1	4	1257	4699	0.947694753577107
R-HSA-75205	Dissolution of Fibrin Clot	  8	1	1	0	8	1258	4695	0
R-HSA-75815	Ubiquitin-dependent degradation of Cyclin D	 38	0.9926072579238	1	3	35	1255	4668	0.374090034306753
R-HSA-75876	Synthesis of very long-chain fatty acyl-CoAs	 18	0.0221100706215542	0.721209446464984	8	10	1250	4693	2.10598834128246
R-HSA-75892	Platelet Adhesion to exposed collagen	  9	0.881750209110067	1	1	8	1257	4695	0.526497085320615
R-HSA-75893	TNF signaling	 30	0.0823491683946107	1	10	20	1248	4683	1.57949125596184
R-HSA-75953	RNA Polymerase II Transcription Initiation	 31	0.323951773629733	1	8	23	1250	4680	1.22283194009949
R-HSA-75955	RNA Polymerase II Transcription Elongation	 36	0.00411854372452668	0.423715563331436	15	21	1243	4682	1.97436406995231
R-HSA-76005	Response to elevated platelet cytosolic Ca2+	 86	0.755604805446337	1	16	70	1242	4633	0.881576514955448
R-HSA-76009	Platelet Aggregation (Plug Formation)	 21	0.851361715004481	1	3	18	1255	4685	0.676924823983648
R-HSA-76042	RNA Polymerase II Transcription Initiation And Promoter Clearance	 31	0.323951773629733	1	8	23	1250	4680	1.22283194009949
R-HSA-76046	RNA Polymerase III Transcription Initiation	 28	0.734415020592046	1	5	23	1253	4680	0.846156029979559
R-HSA-76061	RNA Polymerase III Transcription Initiation From Type 1 Promoter	 21	0.67594281950565	1	4	17	1254	4686	0.902566431978197
R-HSA-76066	RNA Polymerase III Transcription Initiation From Type 2 Promoter	 21	0.67594281950565	1	4	17	1254	4686	0.902566431978197
R-HSA-76071	RNA Polymerase III Transcription Initiation From Type 3 Promoter	 23	0.746858372799286	1	4	19	1254	4684	0.824082394414875
R-HSA-77075	RNA Pol II CTD phosphorylation and interaction with CE	 15	0.193605883409086	1	5	10	1253	4693	1.57949125596184
R-HSA-77111	Synthesis of Ketone Bodies	  6	0.112803303351911	1	3	3	1255	4700	2.36923688394277
R-HSA-77286	mitochondrial fatty acid beta-oxidation of saturated fatty acids	  7	0.809900309657012	1	1	6	1257	4697	0.676924823983648
R-HSA-77289	Mitochondrial Fatty Acid Beta-Oxidation	 25	0.805251530423266	1	4	21	1254	4682	0.758155802861685
R-HSA-77346	Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA	  5	0.694448590316415	1	1	4	1257	4699	0.947694753577107
R-HSA-77387	Insulin receptor recycling	 16	0.881342634259459	1	2	14	1256	4689	0.592309220985692
R-HSA-774815	Nucleosome assembly	 20	0.635673802887573	1	4	16	1254	4687	0.947694753577107
R-HSA-77588	SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs	  7	0.809900309657012	1	1	6	1257	4697	0.676924823983648
R-HSA-77595	Processing of Intronless Pre-mRNAs	 17	0.129308606576508	1	6	11	1252	4692	1.67240250631254
R-HSA-804914	Transport of fatty acids	  5	1	1	0	5	1258	4698	0
R-HSA-844456	The NLRP3 inflammasome	 10	0.906743192466844	1	1	9	1257	4694	0.473847376788553
R-HSA-877300	Interferon gamma signaling	 52	0.551506862733625	1	11	41	1247	4662	1.00236945089886
R-HSA-877312	Regulation of IFNG signaling	 10	0.00835059869339327	0.423715563331436	6	4	1252	4699	2.84308426073132
R-HSA-879415	Advanced glycosylation endproduct receptor signaling	  9	0.881750209110067	1	1	8	1257	4695	0.526497085320615
R-HSA-879518	Transport of organic anions	  7	0.453498803768073	1	2	5	1256	4698	1.3538496479673
R-HSA-881907	Gastrin-CREB signalling pathway via PKC and MAPK	 99	0.997109250593293	1	11	88	1247	4615	0.526497085320615
R-HSA-8847993	ERBB2 Activates PTK6 Signaling	  9	0.596590649481565	1	2	7	1256	4696	1.05299417064123
R-HSA-8848021	Signaling by PTK6	 37	0.823466720611133	1	6	31	1252	4672	0.768401151549005
R-HSA-8849469	PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1	  6	0.758985808815735	1	1	5	1257	4698	0.789745627980922
R-HSA-8849471	PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases	 12	0.942006117300883	1	1	11	1257	4692	0.394872813990461
R-HSA-8849473	PTK6 Expression	  5	0.694448590316415	1	1	4	1257	4699	0.947694753577107
R-HSA-8849932	Synaptic adhesion-like molecules	 18	0.98606788331447	1	1	17	1257	4686	0.263248542660307
R-HSA-8850843	Phosphate bond hydrolysis by NTPDase proteins	  5	0.694448590316415	1	1	4	1257	4699	0.947694753577107
R-HSA-8851680	Butyrophilin (BTN) family interactions	  5	0.285442766330515	1	2	3	1256	4700	1.89538950715421
R-HSA-8851708	Signaling by FGFR2 IIIa TM	 13	0.119008035120833	1	5	8	1253	4695	1.8224899107252
R-HSA-8851805	MET activates RAS signaling	 10	0.906743192466844	1	1	9	1257	4694	0.473847376788553
R-HSA-8851907	MET activates PI3K/AKT signaling	  6	0.758985808815735	1	1	5	1257	4698	0.789745627980922
R-HSA-8852135	Protein ubiquitination	 48	0.3043734960997	1	12	36	1246	4667	1.18461844197138
R-HSA-8852276	The role of GTSE1 in G2/M progression after G2 checkpoint	 51	0.999427426891732	1	3	48	1255	4655	0.27873375105209
R-HSA-8853334	Signaling by FGFR3 fusions in cancer	 10	0.35569981181152	1	3	7	1255	4696	1.42154213036566
R-HSA-8853338	Signaling by FGFR3 point mutants in cancer	 14	0.154445975766771	1	5	9	1253	4694	1.69231205995912
R-HSA-8853659	RET signaling	 21	0.13514556222995	1	7	14	1251	4689	1.57949125596184
R-HSA-8854050	FBXL7 down-regulates AURKA during mitotic entry and in early mitosis	 42	0.986310980693508	1	4	38	1254	4665	0.451283215989098
R-HSA-8854214	TBC/RABGAPs	 30	0.992739157142693	1	2	28	1256	4675	0.315898251192369
R-HSA-8854518	AURKA Activation by TPX2	 52	0.00743167896997425	0.423715563331436	19	33	1239	4670	1.73136541518894
R-HSA-8856688	Golgi-to-ER retrograde transport	 89	0.87052711643622	1	15	74	1243	4629	0.79861917436273
R-HSA-8856825	Cargo recognition for clathrin-mediated endocytosis	 73	0.184315947336393	1	19	54	1239	4649	1.23330139164144
R-HSA-8857538	PTK6 promotes HIF1A stabilization	  6	0.758985808815735	1	1	5	1257	4698	0.789745627980922
R-HSA-8862803	Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models	 18	0.545978248712532	1	4	14	1254	4689	1.05299417064123
R-HSA-8863678	Neurodegenerative Diseases	 18	0.545978248712532	1	4	14	1254	4689	1.05299417064123
R-HSA-8863795	Downregulation of ERBB2 signaling	 22	0.873207475913891	1	3	19	1255	4684	0.646155513802573
R-HSA-8864260	Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors	 28	0.871815972171414	1	4	24	1254	4679	0.676924823983648
R-HSA-8865999	MET activates PTPN11	  5	0.285442766330515	1	2	3	1256	4700	1.89538950715421
R-HSA-8866376	Reelin signalling pathway	  6	0.758985808815735	1	1	5	1257	4698	0.789745627980922
R-HSA-8866427	VLDLR internalisation and degradation	 10	1	1	0	10	1258	4693	0
R-HSA-8866652	Synthesis of active ubiquitin: roles of E1 and E2 enzymes	 19	0.195838194017673	1	6	13	1252	4690	1.49636013722701
R-HSA-8866654	E3 ubiquitin ligases ubiquitinate target proteins	 35	0.630040310067862	1	7	28	1251	4675	0.947694753577107
R-HSA-8866904	Negative regulation of activity of TFAP2 (AP-2) family transcription factors	  8	0.850065813595789	1	1	7	1257	4696	0.592309220985692
R-HSA-8866907	Activation of the TFAP2 (AP-2) family of transcription factors	  9	0.596590649481565	1	2	7	1256	4696	1.05299417064123
R-HSA-8866910	TFAP2 (AP-2) family regulates transcription of growth factors and their receptors	  8	0.850065813595789	1	1	7	1257	4696	0.592309220985692
R-HSA-8868766	rRNA processing in the mitochondrion	  6	0.758985808815735	1	1	5	1257	4698	0.789745627980922
R-HSA-8868773	rRNA processing in the nucleus and cytosol	 79	0.399623056025037	1	18	61	1240	4642	1.07965225091063
R-HSA-8873719	RAB geranylgeranylation	 45	0.97434482309854	1	5	40	1253	4663	0.526497085320615
R-HSA-8874081	MET activates PTK2 signaling	 21	0.67594281950565	1	4	17	1254	4686	0.902566431978197
R-HSA-8874211	CREB3 factors activate genes	  6	0.371762497819815	1	2	4	1256	4699	1.57949125596184
R-HSA-8875360	InlB-mediated entry of Listeria monocytogenes into host cell	 10	0.140936259771786	1	4	6	1254	4697	1.89538950715421
R-HSA-8875513	MET interacts with TNS proteins	  5	1	1	0	5	1258	4698	0
R-HSA-8875555	MET activates RAP1 and RAC1	  9	0.596590649481565	1	2	7	1256	4696	1.05299417064123
R-HSA-8875656	MET receptor recycling	  9	0.881750209110067	1	1	8	1257	4695	0.526497085320615
R-HSA-8875878	MET promotes cell motility	 30	0.630596547005804	1	6	24	1252	4679	0.947694753577107
R-HSA-8876198	RAB GEFs exchange GTP for GDP on RABs	 69	0.496037716749381	1	15	54	1243	4649	1.03010299301859
R-HSA-8876384	Listeria monocytogenes entry into host cells	 13	0.287098043862492	1	4	9	1254	4694	1.45799192858016
R-HSA-8876725	Protein methylation	 10	0.140936259771786	1	4	6	1254	4697	1.89538950715421
R-HSA-8878159	Transcriptional regulation by RUNX3	 83	0.995562363526039	1	9	74	1249	4629	0.513810408565901
R-HSA-8878166	Transcriptional regulation by RUNX2	 91	0.83088017883533	1	16	75	1242	4628	0.833138244902951
R-HSA-888590	GABA synthesis, release, reuptake and degradation	 18	0.918744185015892	1	2	16	1256	4687	0.526497085320615
R-HSA-8934593	Regulation of RUNX1 Expression and Activity	 16	0.0348653428939975	0.86846399572321	7	9	1251	4694	2.07308227344992
R-HSA-8934903	Receptor Mediated Mitophagy	  7	0.809900309657012	1	1	6	1257	4697	0.676924823983648
R-HSA-8935964	RUNX1 regulates expression of components of tight junctions	  5	1	1	0	5	1258	4698	0
R-HSA-8936459	RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function	 38	0.0866613258252465	1	12	26	1246	4677	1.49636013722701
R-HSA-8939236	RUNX1 regulates transcription of genes involved in differentiation of HSCs	 63	0.98776521704904	1	7	56	1251	4647	0.526497085320615
R-HSA-8939242	RUNX1 regulates transcription of genes involved in differentiation of keratinocytes	  6	0.758985808815735	1	1	5	1257	4698	0.789745627980922
R-HSA-8939243	RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known	 23	0.0129432746052269	0.578684096835011	10	13	1248	4690	2.06020598603719
R-HSA-8939246	RUNX1 regulates transcription of genes involved in differentiation of myeloid cells	  6	0.112803303351911	1	3	3	1255	4700	2.36923688394277
R-HSA-8939902	Regulation of RUNX2 expression and activity	 54	0.833812546586967	1	9	45	1249	4658	0.789745627980922
R-HSA-8940973	RUNX2 regulates osteoblast differentiation	 19	0.372319270008444	1	5	14	1253	4689	1.24696678102251
R-HSA-8941284	RUNX2 regulates chondrocyte maturation	  5	0.285442766330515	1	2	3	1256	4700	1.89538950715421
R-HSA-8941326	RUNX2 regulates bone development	 26	0.164785976879534	1	8	18	1250	4685	1.45799192858016
R-HSA-8941332	RUNX2 regulates genes involved in cell migration	  6	0.758985808815735	1	1	5	1257	4698	0.789745627980922
R-HSA-8941856	RUNX3 regulates NOTCH signaling	 10	0.656813358899076	1	2	8	1256	4695	0.947694753577107
R-HSA-8941858	Regulation of RUNX3 expression and activity	 41	0.999300778266394	1	2	39	1256	4664	0.231145061848075
R-HSA-8943723	Regulation of PTEN mRNA translation	  9	0.0244332470772493	0.743856633240702	5	4	1253	4699	2.63248542660307
R-HSA-8943724	Regulation of PTEN gene transcription	 36	0.802006453228929	1	6	30	1252	4673	0.789745627980922
R-HSA-8948216	Collagen chain trimerization	 23	0.552202797361461	1	5	18	1253	4685	1.03010299301859
R-HSA-8948700	Competing endogenous RNAs (ceRNAs) regulate PTEN translation	  8	0.0131159546059538	0.578684096835011	5	3	1253	4700	2.96154610492846
R-HSA-8948747	Regulation of PTEN localization	  6	0.758985808815735	1	1	5	1257	4698	0.789745627980922
R-HSA-8948751	Regulation of PTEN stability and activity	 54	0.998421695003395	1	4	50	1254	4653	0.35099805688041
R-HSA-8949215	Mitochondrial calcium ion transport	 13	0.954269742184979	1	1	12	1257	4691	0.364497982145041
R-HSA-8949613	Cristae formation	 18	0.918744185015892	1	2	16	1256	4687	0.526497085320615
R-HSA-8949664	Processing of SMDT1	 10	0.906743192466844	1	1	9	1257	4694	0.473847376788553
R-HSA-8950505	Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation	 24	0.777567928722182	1	4	20	1254	4683	0.789745627980922
R-HSA-8951430	RUNX3 regulates WNT signaling	  8	1	1	0	8	1258	4695	0
R-HSA-8951671	RUNX3 regulates YAP1-mediated transcription	 17	0.901691816657284	1	2	15	1256	4688	0.55746750210418
R-HSA-8951936	RUNX3 regulates p14-ARF	  8	0.850065813595789	1	1	7	1257	4696	0.592309220985692
R-HSA-8953750	Transcriptional Regulation by E2F6	 16	0.446016886428218	1	4	12	1254	4691	1.18461844197138
R-HSA-8955332	Carboxyterminal post-translational modifications of tubulin	 22	0.962823796383355	1	2	20	1256	4683	0.430770342535048
R-HSA-8956319	Nucleobase catabolism	 18	0.325876881589819	1	5	13	1253	4690	1.31624271330154
R-HSA-8956320	Nucleobase biosynthesis	 10	0.906743192466844	1	1	9	1257	4694	0.473847376788553
R-HSA-8956321	Nucleotide salvage	 13	0.538576769291448	1	3	10	1255	4693	1.09349394643512
R-HSA-8957275	Post-translational protein phosphorylation	 66	0.851717686835205	1	11	55	1247	4648	0.789745627980922
R-HSA-8957322	Metabolism of steroids	 88	0.0628794777851445	1	25	63	1233	4640	1.34615732042203
R-HSA-8963889	Assembly of active LPL and LIPC lipase complexes	  9	0.596590649481565	1	2	7	1256	4696	1.05299417064123
R-HSA-8963896	HDL assembly	  5	0.694448590316415	1	1	4	1257	4699	0.947694753577107
R-HSA-8963898	Plasma lipoprotein assembly	 10	0.656813358899076	1	2	8	1256	4695	0.947694753577107
R-HSA-8963899	Plasma lipoprotein remodeling	 13	0.794842618691727	1	2	11	1256	4692	0.728995964290082
R-HSA-8964038	LDL clearance	 14	0.82853459821947	1	2	12	1256	4691	0.676924823983648
R-HSA-8964043	Plasma lipoprotein clearance	 20	0.944837320715584	1	2	18	1256	4685	0.473847376788553
R-HSA-8978934	Metabolism of cofactors	  6	1	1	0	6	1258	4697	0
R-HSA-8979227	Triglyceride metabolism	 19	0.797707662304944	1	3	16	1255	4687	0.748180068613505
R-HSA-8982491	Glycogen metabolism	 19	0.592287309700289	1	4	15	1254	4688	0.997573424818007
R-HSA-8983432	Interleukin-15 signaling	  9	0.596590649481565	1	2	7	1256	4696	1.05299417064123
R-HSA-8984722	Interleukin-35 Signalling	 11	0.186227514654976	1	4	7	1254	4696	1.72308137014019
R-HSA-9006921	Integrin signaling	 16	0.687843131132348	1	3	13	1255	4690	0.888463831478537
R-HSA-9006927	Signaling by Non-Receptor Tyrosine Kinases	 37	0.823466720611133	1	6	31	1252	4672	0.768401151549005
R-HSA-9006931	Signaling by Nuclear Receptors	 28	0.98900310510335	1	2	26	1256	4677	0.338462411991824
R-HSA-9006936	Signaling by TGF-beta family members	 75	0.827812131617254	1	13	62	1245	4641	0.821335453100159
R-HSA-9007101	Rab regulation of trafficking	 91	0.83088017883533	1	16	75	1242	4628	0.833138244902951
R-HSA-901032	ER Quality Control Compartment (ERQC)	 13	0.119008035120833	1	5	8	1253	4695	1.8224899107252
R-HSA-901042	Calnexin/calreticulin cycle	 18	0.161096514800637	1	6	12	1252	4691	1.57949125596184
R-HSA-9010553	Regulation of expression of SLITs and ROBOs	 82	0.681469158557238	1	16	66	1242	4637	0.924580247392299
R-HSA-9010642	ROBO receptors bind AKAP5	  6	0.758985808815735	1	1	5	1257	4698	0.789745627980922
R-HSA-9013973	TICAM1-dependent activation of IRF3/IRF7	  7	0.453498803768073	1	2	5	1256	4698	1.3538496479673
R-HSA-9014325	TICAM1,TRAF6-dependent induction of TAK1 complex	  8	0.227769868815571	1	3	5	1255	4698	1.77692766295707
R-HSA-909733	Interferon alpha/beta signaling	 45	0.76272208455203	1	8	37	1250	4666	0.842395336512983
R-HSA-912446	Meiotic recombination	 18	0.545978248712532	1	4	14	1254	4689	1.05299417064123
R-HSA-912526	Interleukin receptor SHC signaling	 13	0.794842618691727	1	2	11	1256	4692	0.728995964290082
R-HSA-912631	Regulation of signaling by CBL	 14	0.82853459821947	1	2	12	1256	4691	0.676924823983648
R-HSA-912694	Regulation of IFNA signaling	  9	0.100768114047514	1	4	5	1254	4698	2.10598834128246
R-HSA-913709	O-linked glycosylation of mucins	 31	0.664278496324224	1	6	25	1252	4678	0.917123955074619
R-HSA-917729	Endosomal Sorting Complex Required For Transport (ESCRT)	 18	0.545978248712532	1	4	14	1254	4689	1.05299417064123
R-HSA-917937	Iron uptake and transport	 37	0.968203775362997	1	4	33	1254	4670	0.512267434366004
R-HSA-917977	Transferrin endocytosis and recycling	 21	0.67594281950565	1	4	17	1254	4686	0.902566431978197
R-HSA-918233	TRAF3-dependent IRF activation pathway	 10	0.656813358899076	1	2	8	1256	4695	0.947694753577107
R-HSA-927802	Nonsense-Mediated Decay (NMD)	 39	0.0516518818880131	1	13	26	1245	4677	1.57949125596184
R-HSA-933541	TRAF6 mediated IRF7 activation	 15	0.642500710250324	1	3	12	1255	4691	0.947694753577107
R-HSA-933542	TRAF6 mediated NF-kB activation	 19	0.797707662304944	1	3	16	1255	4687	0.748180068613505
R-HSA-933543	NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10	  8	0.850065813595789	1	1	7	1257	4696	0.592309220985692
R-HSA-936440	Negative regulators of DDX58/IFIH1 signaling	 27	0.702858098745796	1	5	22	1253	4681	0.877495142201025
R-HSA-936837	Ion transport by P-type ATPases	 38	0.409761521143426	1	9	29	1249	4674	1.12227010292026
R-HSA-936964	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	 11	0.186227514654976	1	4	7	1254	4696	1.72308137014019
R-HSA-937039	IRAK1 recruits IKK complex	  7	0.809900309657012	1	1	6	1257	4697	0.676924823983648
R-HSA-937041	IKK complex recruitment mediated by RIP1	 14	0.34015887110078	1	4	10	1254	4693	1.3538496479673
R-HSA-937061	TRIF(TICAM1)-mediated TLR4 signaling 	 75	0.414076460512097	1	17	58	1241	4645	1.07405405405405
R-HSA-937072	TRAF6-mediated induction of TAK1 complex within TLR4 complex	  8	0.227769868815571	1	3	5	1255	4698	1.77692766295707
R-HSA-975110	TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling	  6	1	1	0	6	1258	4697	0
R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	 66	0.765174296761021	1	12	54	1246	4649	0.861540685070097
R-HSA-975144	IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation	  7	0.809900309657012	1	1	6	1257	4697	0.676924823983648
R-HSA-975155	MyD88 dependent cascade initiated on endosome	 68	0.800753933476291	1	12	56	1246	4647	0.83620125315627
R-HSA-975163	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	  8	0.227769868815571	1	3	5	1255	4698	1.77692766295707
R-HSA-975576	N-glycan antennae elongation in the medial/trans-Golgi	 15	0.85715519636857	1	2	13	1256	4690	0.631796502384738
R-HSA-975577	N-Glycan antennae elongation	  9	1	1	0	9	1258	4694	0
R-HSA-975578	Reactions specific to the complex N-glycan synthesis pathway	  6	0.371762497819815	1	2	4	1256	4699	1.57949125596184
R-HSA-975634	Retinoid metabolism and transport	 24	0.908530114618068	1	3	21	1255	4682	0.592309220985692
R-HSA-975871	MyD88 cascade initiated on plasma membrane	 63	0.805252904474666	1	11	52	1247	4651	0.82735256264668
R-HSA-975956	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	 22	0.164036518152948	1	7	15	1251	4688	1.50769619887267
R-HSA-975957	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	 39	0.0516518818880131	1	13	26	1245	4677	1.57949125596184
R-HSA-977068	Termination of O-glycan biosynthesis	  7	0.809900309657012	1	1	6	1257	4697	0.676924823983648
R-HSA-977225	Amyloid fiber formation	 30	0.904403630664436	1	4	26	1254	4677	0.631796502384738
R-HSA-977347	Serine biosynthesis	  7	0.809900309657012	1	1	6	1257	4697	0.676924823983648
R-HSA-977441	GABA A receptor activation	  9	0.881750209110067	1	1	8	1257	4695	0.526497085320615
R-HSA-977443	GABA receptor activation	 39	0.993891933616385	1	3	36	1255	4667	0.364497982145041
R-HSA-977444	GABA B receptor activation	 30	0.992739157142693	1	2	28	1256	4675	0.315898251192369
R-HSA-977606	Regulation of Complement cascade	 23	0.892159841381082	1	3	20	1255	4683	0.618061795811156
R-HSA-982772	Growth hormone receptor signaling	 15	0.193605883409086	1	5	10	1253	4693	1.57949125596184
R-HSA-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	 17	0.280104557481713	1	5	12	1253	4691	1.39366875526045
R-HSA-983189	Kinesins	 32	0.977380083756183	1	3	29	1255	4674	0.444231915739269
R-HSA-983231	Factors involved in megakaryocyte development and platelet production	 91	0.562991578632807	1	19	72	1239	4631	0.989351665822254
R-HSA-983695	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	 30	0.28953565275774	1	8	22	1250	4681	1.26359300476948
R-HSA-983705	Signaling by the B Cell Receptor (BCR)	 94	0.718929106764636	1	18	76	1240	4627	0.907367317254677
R-HSA-991365	Activation of GABAB receptors	 30	0.992739157142693	1	2	28	1256	4675	0.315898251192369
R-HSA-997269	Inhibition of adenylate cyclase pathway	 13	0.794842618691727	1	2	11	1256	4692	0.728995964290082
R-HSA-997272	Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits	 17	1	1	0	17	1258	4686	0
